Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G1B,Phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,50373,-0.0431476157993167,0.0273933326701951,-0.0968385478328991,0.0105433162342657,0.115245120733443
PLA2G1B,Phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,48213,-0.0228600946880248,0.0303196602908714,-0.0822866288581327,0.0365664394820832,0.450876958404546
PLA2G1B,Phospholipase A2,Physical activities,X1070.Time spent watching television (TV),51593,0.000836223640887385,0.0280852762254413,-0.0542109177609777,0.0558833650427524,0.976247201292179
PLA2G1B,Phospholipase A2,Physical activities,X1080.Time spent using computer,48274,0.00651396346512776,0.0269822908200385,-0.0463713265421477,0.0593992534724033,0.809235113890367
PLA2G1B,Phospholipase A2,Physical activities,X1090.Time spent driving,44035,-0.0351394313633208,0.0310016711663026,-0.0959027068492739,0.0256238441226324,0.257035688132908
PLA2G1B,Phospholipase A2,Lifestyle factors,X1160.Sleep duration,52400,-0.000144915984136636,0.0244408416934167,-0.0480489657032334,0.0477591337349602,0.995269217623628
PLA2G1B,Phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35679,-0.0242486608303491,0.0199369544926203,-0.0633250916358848,0.0148277699751866,0.223927476430559
PLA2G1B,Phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35679,-0.015002446724945,0.0190063033509296,-0.052254801292767,0.022249907842877,0.429941825844733
PLA2G1B,Phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35679,0.00456630792800618,0.0207944793116096,-0.0361908715227486,0.045323487378761,0.82619558551119
PLA2G1B,Phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35679,0.0163002824410883,0.0209308441409124,-0.0247241720751,0.0573247369572765,0.436144501599711
PLA2G1B,Phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35679,0.00190678776076435,0.0209270030087681,-0.0391101381364211,0.0429237136579498,0.927403121315896
PLA2G1B,Phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35679,0.0116168280401299,0.0525522445949435,-0.0913855713659594,0.114619227446219,0.825058173494799
PLA2G1B,Phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35679,0.00623752989006913,0.0548782319977618,-0.101323804825544,0.113798864605682,0.909509828947412
PLA2G1B,Phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35679,-0.0571778518627052,0.0356463443961018,-0.127044686879065,0.0126889831536543,0.108755851447551
PLA2G1B,Phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35679,0.00109362501481588,0.0259295569431476,-0.0497283065937533,0.0519155566233851,0.966359077665107
PLA2G1B,Phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35679,-0.0241043541376986,0.0170414789827277,-0.0575056529438448,0.00929694466844765,0.157277238268764
PLA2G1B,Phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35679,0.0192396354400198,0.0256292392656851,-0.0309936735207231,0.0694729444007626,0.452865967009519
PLA2G1B,Phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35679,-0.0132301522364108,0.0137731981494889,-0.040225620609409,0.0137653161365873,0.336803088546032
PLA2G1B,Phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35679,-0.0148276175241545,0.0180268546704686,-0.050160252678273,0.020505017629964,0.410805916904323
PLA2G1B,Phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35679,0.01187734828006,0.025582490910609,-0.0382643339047337,0.0620190304648536,0.642465273045913
PLA2G1B,Phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35679,0.000355992913251535,0.0241229043170576,-0.0469248995481813,0.0476368853746844,0.988226127955106
PLA2G1B,Phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35679,0.0108071573528185,0.0372950951465357,-0.0622912291343915,0.0839055438400285,0.771998230589946
PLA2G1B,Phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35679,-0.00725448424088418,0.0353661435580305,-0.076572125614624,0.0620631571328556,0.837480813092542
PLA2G1B,Phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35679,-0.0181155150007139,0.0187444062028762,-0.0548545511583512,0.0186235211569234,0.333855530913672
PLA2G1B,Phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35679,-0.000753553184257787,0.0176771250488434,-0.0354007182799908,0.0338936119114752,0.965998814765561
PLA2G1B,Phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35679,0.00276828291979169,0.0224867947947918,-0.0413058348780002,0.0468424007175836,0.902026145390489
PLA2G1B,Phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,35682,-0.0173026339085668,0.049410019242426,-0.114146271623722,0.0795410038065882,0.726211441988656
PLA2G1B,Phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,35680,0.0275748325008591,0.0498980960421468,-0.0702254357417487,0.125375100743467,0.58054068022661
PLA2G1B,Phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,35682,-0.0116097455101263,0.0527121028661342,-0.114925467127749,0.0917059761074967,0.825684795653147
PLA2G1B,Phospholipase A2,Health and medical history,X120098.Mobility problems today,35686,0.0248057749783048,0.0539099900311065,-0.0808578054826639,0.130469355439274,0.645436048803107
PLA2G1B,Phospholipase A2,Health and medical history,X120099.Self-care problems today,35686,0.024781374291546,0.082277013437256,-0.136481572045476,0.186044320628568,0.763275923429264
PLA2G1B,Phospholipase A2,Health and medical history,X120100.Problems doing usual activities,35686,-0.00957407562870387,0.0523189480720402,-0.112119213849903,0.0929710625924949,0.854808112775468
PLA2G1B,Phospholipase A2,Health and medical history,X120101.Pain or discomfort today,35686,-0.0236983728290602,0.0496498375969545,-0.121012054519091,0.0736153088609706,0.633157339542737
PLA2G1B,Phospholipase A2,Health and medical history,X120102.Anxiety or depression today,35686,-0.0329684705989953,0.0626321624593756,-0.155727509019371,0.0897905678213808,0.598640503293517
PLA2G1B,Phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,35664,-0.00302340237501314,0.00602949344344345,-0.0148412095241623,0.00879440477413602,0.616081684549907
PLA2G1B,Phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35661,0.00232757392164837,0.0637478040627228,-0.122618122041288,0.127273269884585,0.970875061392282
PLA2G1B,Phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35651,-0.0588738517163217,0.0667048345727248,-0.189615327478862,0.0718676240462189,0.377483960234211
PLA2G1B,Phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35667,0.0535278728020332,0.0504338525953578,-0.0453224782848681,0.152378223888934,0.288571350756482
PLA2G1B,Phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35666,-0.0842918927937779,0.0510780641707778,-0.184404898568502,0.0158211129809466,0.0989390823808721
PLA2G1B,Phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35677,0.0558870231464266,0.0740261309802705,-0.0892041935749036,0.200978239867757,0.450298346789947
PLA2G1B,Phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,35656,-0.0229044950822108,0.0720509944029159,-0.164124444111926,0.118315453947504,0.750576500639235
PLA2G1B,Phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,35670,0.0271938891795856,0.0708581335149165,-0.111688052509651,0.166075830868822,0.70115458947776
PLA2G1B,Phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35669,0.0576914499662013,0.0971836952366187,-0.132788592697571,0.248171492629974,0.552778337168176
PLA2G1B,Phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35647,0.133984785535006,0.149025920008763,-0.15810601768217,0.426075588752181,0.368648748757547
PLA2G1B,Phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33491,0.0650325226293928,0.0692496042576923,-0.0706967017156842,0.20076174697447,0.347730586841493
PLA2G1B,Phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,50579,0.0260787910511157,0.0594514603411791,-0.0904460712175952,0.142603653319827,0.660914620160725
PLA2G1B,Phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48761,-0.068722506921512,0.0368037571759253,-0.140857870986326,0.00341285714330156,0.0618790036325904
PLA2G1B,Phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,51942,-0.0359812874628592,0.0258420129065032,-0.0866316327596054,0.014669057833887,0.163828164806784
PLA2G1B,Phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,51126,-0.0297514462894219,0.0268268466192689,-0.082332065663189,0.0228291730843452,0.267434730665035
PLA2G1B,Phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,51861,0.108953489214489,0.0264053350132603,0.0571990325884984,0.160707945840479,3.70135604454561e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,50652,0.0779394058719464,0.0265068786555798,0.02598592370701,0.129892888036883,0.00328195248412372
PLA2G1B,Phospholipase A2,Health and medical history,X134.Number of self-reported cancers,52609,-0.0370168160990392,0.0408320803703427,-0.117047693624911,0.0430140614268324,0.364647747112134
PLA2G1B,Phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52610,0.0616326907697688,0.0266466283977121,0.00940529911025302,0.113860082429285,0.0207332442810895
PLA2G1B,Phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",52610,0.00200066157725112,0.0254614710266523,-0.0479038216349874,0.0519051447894896,0.937370516992663
PLA2G1B,Phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,52610,0.0762989727562894,0.0256715006070421,0.0259828315664869,0.126615113946092,0.00296044523222402
PLA2G1B,Phospholipase A2,Diet and food preferences,X1438.Bread intake,51981,0.00591103622632826,0.00355943444199028,-0.0010654552799727,0.0128875277326292,0.0967940512865691
PLA2G1B,Phospholipase A2,Diet and food preferences,X1458.Cereal intake,51625,0.168034497063936,0.025175703649393,0.118690117911126,0.217378876216746,2.53917571872529e-11
PLA2G1B,Phospholipase A2,Diet and food preferences,X1488.Tea intake,51901,0.0265039380750448,0.00345874005534204,0.0197248075665744,0.0332830685835152,1.89061620998507e-14
PLA2G1B,Phospholipase A2,Diet and food preferences,X1498.Coffee intake,50887,-0.0859025110432668,0.0253880940986022,-0.135663175476527,-0.0361418466100064,0.000716753164396014
PLA2G1B,Phospholipase A2,Diet and food preferences,X1528.Water intake,50708,-0.0435376939917587,0.0253370058209382,-0.0931982254007975,0.00612283741728015,0.0857482617564055
PLA2G1B,Phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,45176,-0.15335323144129,0.0302324048615483,-0.212608744969925,-0.0940977179126553,3.97064942930182e-07
PLA2G1B,Phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,45173,-0.10185866323304,0.0309536847721384,-0.162527885386431,-0.0411894410796482,0.00100162131838973
PLA2G1B,Phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,45222,-0.103043928655336,0.0342087466109579,-0.170093072012813,-0.0359947852978586,0.00259757691178715
PLA2G1B,Phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,45156,-0.112803992924771,0.0323875296606865,-0.176283551059716,-0.0493244347898251,0.00049725787392543
PLA2G1B,Phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,45205,-0.0257707017474302,0.0495763050326533,-0.122940259611431,0.0713988561165702,0.603196972173512
PLA2G1B,Phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,46203,-0.0342462158466516,0.0307971108189458,-0.0946085530517853,0.026116121358482,0.266156260720725
PLA2G1B,Phospholipase A2,Health and medical history,X1807.Father's age at death,50450,0.00278962376037751,0.00332512615959905,-0.00372762351243664,0.00930687103319165,0.401505255303997
PLA2G1B,Phospholipase A2,Health and medical history,X1845.Mother's age,32646,0.0159405749233668,0.0154659985265461,-0.0143727821886635,0.046253932035397,0.302760700486864
PLA2G1B,Phospholipase A2,Health and medical history,X1873.Number of full brothers,52183,-0.040823500635801,0.0243799552300574,-0.0886082128867134,0.00696121161511146,0.0940518925913674
PLA2G1B,Phospholipase A2,Health and medical history,X1883.Number of full sisters,52190,0.0016707825905934,0.0244394875180871,-0.0462306129448573,0.0495721781260441,0.945496425255221
PLA2G1B,Phospholipase A2,Physical measures,X20015.Sitting height,52438,-0.0186178032616536,0.00444403293188255,-0.0273281078081434,-0.00990749871516378,2.8073247013712e-05
PLA2G1B,Phospholipase A2,Cognitive function,X20016.Fluid intelligence score,36844,-0.0465645693094773,0.0399304858337738,-0.124828321543674,0.0316991829247195,0.243593927775023
PLA2G1B,Phospholipase A2,Cognitive function,X20018.Prospective memory result,37208,-0.0956229415219029,0.0489183885688444,-0.191502983116838,0.000257100073032188,0.0506479801068993
PLA2G1B,Phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36720,0.0065826575417167,0.00597814466256259,-0.00513450599690598,0.0182998210803394,0.270879438219838
PLA2G1B,Phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36707,0.00574974487603553,0.00600772311489706,-0.0060253924291627,0.0175248821812338,0.338568321718967
PLA2G1B,Phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,52299,0.00334188407674407,0.00362788969718743,-0.00376877972974329,0.0104525478832314,0.356974040971297
PLA2G1B,Phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,49131,0.00541203703388148,0.00750784645658066,-0.00930334202101662,0.0201274160887796,0.471009775820953
PLA2G1B,Phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48673,-0.0243476835843682,0.0159742316498437,-0.0556571776180618,0.00696181044932539,0.127478748920736
PLA2G1B,Phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48638,0.0174767563509231,0.0213284401048531,-0.024326986254589,0.0592804989564351,0.412562060202018
PLA2G1B,Phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48646,-0.0111782356372241,0.0203103420789398,-0.050986506111946,0.0286300348374978,0.582070837835413
PLA2G1B,Phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48669,0.0115261972891896,0.0141240300606846,-0.0161569016297523,0.0392092962081315,0.414470078953154
PLA2G1B,Phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48848,0.00614417395185756,0.00940596859791871,-0.0122915245000631,0.0245798724037782,0.513621609932054
PLA2G1B,Phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48788,0.00157520471774926,0.0115238072863549,-0.0210114575635064,0.0241618669990049,0.891276175344482
PLA2G1B,Phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48690,0.000793261768673991,0.014903583068648,-0.028417761045876,0.030004284583224,0.957552189847145
PLA2G1B,Phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48843,-0.0159261409446323,0.0101550872236015,-0.0358301119028913,0.00397783001362668,0.116829130239406
PLA2G1B,Phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48835,0.00423162019439552,0.00943267225598308,-0.0142564174273313,0.0227196578161224,0.653715742372021
PLA2G1B,Phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48711,-0.0152096834455804,0.0134681075642028,-0.0416071742714178,0.011187807380257,0.258780497440252
PLA2G1B,Phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50257,0.0334633083298514,0.00817971806746016,0.0174310609176294,0.0494955557420733,4.31095910902822e-05
PLA2G1B,Phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,50093,-0.011832751024126,0.0106456359898721,-0.0326981975642754,0.00903269551602336,0.266360859759395
PLA2G1B,Phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,50000,0.0105887498314388,0.0237373809788893,-0.0359365168871843,0.0571140165500618,0.655544742506204
PLA2G1B,Phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,50026,0.0109766021110805,0.0148364155683199,-0.0181027724028265,0.0400559766249875,0.45940425947042
PLA2G1B,Phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,50188,0.00360968244297236,0.00897461361565701,-0.0139805602437154,0.0211999251296601,0.687533323853371
PLA2G1B,Phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,50047,-0.0273775094477442,0.0171818296688708,-0.0610538955987309,0.00629887670324253,0.111085875890934
PLA2G1B,Phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,50033,0.0121257908156691,0.0144923405344888,-0.016279196631929,0.0405307782632673,0.402768893557748
PLA2G1B,Phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,50037,-0.0187715893222169,0.0127935459966864,-0.0438469394757221,0.00630376083128841,0.142317643962765
PLA2G1B,Phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,50085,-0.0104611007268731,0.0143673767068688,-0.0386211590723359,0.0176989576185897,0.466551428277061
PLA2G1B,Phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50236,-0.00721321970495924,0.00795916507576583,-0.0228131832534603,0.00838674384354178,0.364798871786712
PLA2G1B,Phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,50096,-0.0240294670050548,0.0122079992113682,-0.0479571454593365,-0.000101788550773193,0.0490423719638416
PLA2G1B,Phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46396,0.0216747817173612,0.0103317116406487,0.0014246269016898,0.0419249365330325,0.0359295241876582
PLA2G1B,Phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46218,-0.0379003575149611,0.0361368690745822,-0.108728620901142,0.0329279058712201,0.294284948796197
PLA2G1B,Phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46209,-0.030851293016976,0.0385133375204007,-0.106337434556961,0.0446348485230094,0.423111120285944
PLA2G1B,Phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46241,-0.00656954287385657,0.0157928612905582,-0.0375235510033507,0.0243844652556376,0.677428557242448
PLA2G1B,Phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46235,0.00817806974869929,0.0214780038574406,-0.0339188178118842,0.0502749573092828,0.703382461175672
PLA2G1B,Phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46268,-0.0101090375185101,0.0172914222106828,-0.0440002250514484,0.0237821500144282,0.55880607033984
PLA2G1B,Phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46233,0.0104806267071044,0.0192205772125006,-0.0271917046293967,0.0481529580436055,0.585567008308024
PLA2G1B,Phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46226,-0.0246096728706361,0.019369663995051,-0.062574214300936,0.0133548685596638,0.203914476892825
PLA2G1B,Phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46247,-0.00736218500773009,0.0158677523714597,-0.0384629796557912,0.023738609640331,0.642674080850388
PLA2G1B,Phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46263,0.0253250762976986,0.0187076699885645,-0.0113419568798878,0.0619921094752849,0.175841443536075
PLA2G1B,Phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46441,-0.00704665005249355,0.00872917191719078,-0.0241558270101875,0.0100625269052004,0.419531879460134
PLA2G1B,Phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46331,-0.0579934890788081,0.0119964064534268,-0.0815064457275246,-0.0344805324300916,1.34814864468481e-06
PLA2G1B,Phospholipase A2,Mental health,X20127.Neuroticism score,47593,0.000973682452691762,0.0257558373852687,-0.0495077588224348,0.0514551237278183,0.969844093821304
PLA2G1B,Phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36844,-0.0152022882816128,0.04057076751654,-0.0947209926140313,0.0643164160508056,0.707886262922084
PLA2G1B,Phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,37136,-0.0151647797758752,0.00596365878004513,-0.0268535509847637,-0.00347600856698679,0.0110135753633632
PLA2G1B,Phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,37136,-0.0169016090163892,0.0061623555695505,-0.0289798259327082,-0.00482339210007023,0.00610694010205624
PLA2G1B,Phospholipase A2,Cognitive function,X20191.Fluid intelligence score,34403,-0.0295534157521538,0.0506763500921615,-0.12887906193279,0.0697722304284828,0.559797678403645
PLA2G1B,Phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34404,-0.0664349311751498,0.0519929494409393,-0.168341112079391,0.0354712497290912,0.201388273381965
PLA2G1B,Phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,33742,0.0199912419540357,0.0551447314105987,-0.0880924316107378,0.128074915518809,0.716977998829289
PLA2G1B,Phospholipase A2,Physical measures,X20255.Spirometry QC measure,46484,-0.0269172599455553,0.032466341736728,-0.0905512897495422,0.0367167698584316,0.407069445341932
PLA2G1B,Phospholipase A2,Eye measures,X20261.avMSE,34404,-0.0171503762729102,0.0067121397885443,-0.030306170258457,-0.00399458228736333,0.0106430414107464
PLA2G1B,Phospholipase A2,Eye measures,X20262.Myopia diagnosis,34404,0.164170056032164,0.0641138449863537,0.0385069198589112,0.289833192205417,0.0104770334703027
PLA2G1B,Phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,42748,-0.049108750763772,0.00447098849908306,-0.0578718882219748,-0.0403456133055692,5.99336847399843e-28
PLA2G1B,Phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,42776,-0.0259702227212981,0.00459847414451584,-0.0349832320445491,-0.016957213398047,1.65990933157817e-08
PLA2G1B,Phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36513,0.0126357419415356,0.0284788260063679,-0.0431827570309456,0.0684542409140167,0.657280562436376
PLA2G1B,Phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36513,0.0258712027751574,0.0533652300237235,-0.0787246480713408,0.130467053621656,0.627836197295958
PLA2G1B,Phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36514,0.0834588866896834,0.0895739797538072,-0.0921061136277787,0.259023887007146,0.351506099733316
PLA2G1B,Phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36514,0.027909911667983,0.0261560054668972,-0.0233558590471355,0.0791756823831015,0.285981927813057
PLA2G1B,Phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36514,-0.00684784002078502,0.0544580308213476,-0.113585580430626,0.0998899003890563,0.89993701589428
PLA2G1B,Phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36517,0.0791801428296809,0.0688237371266662,-0.0557143819385848,0.214074667597947,0.249984931303223
PLA2G1B,Phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36517,0.0541999215775084,0.0428216575109933,-0.0297305271440384,0.138130370299055,0.205656177770023
PLA2G1B,Phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36517,0.0835425790514058,0.0514506116838294,-0.0173006198488998,0.184385777951712,0.104473674510615
PLA2G1B,Phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36517,0.0144239606231067,0.0793513929934468,-0.141104769644049,0.169952690890262,0.855765708929355
PLA2G1B,Phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36517,0.0850725606867872,0.0923333264706036,-0.0959007591955958,0.26604588056917,0.356891008566598
PLA2G1B,Phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36517,0.141968852088411,0.0566889720586521,0.0308584668534526,0.253079237323369,0.0122893345795665
PLA2G1B,Phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36517,0.113247786033688,0.0954237338351003,-0.0737827322831086,0.300278304350485,0.235349570785776
PLA2G1B,Phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36517,0.148833511072647,0.0659731578750589,0.0195261216375313,0.278140900507762,0.0241018443991831
PLA2G1B,Phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36516,0.0204833157573613,0.0908586533447839,-0.157599644798415,0.198566276313138,0.821642081969841
PLA2G1B,Phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36516,0.0727311875091551,0.0353933903447578,0.00336014243342991,0.14210223258488,0.0399204914412927
PLA2G1B,Phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36516,-0.0100552793233832,0.0659970440947727,-0.139409485749138,0.119298927102371,0.878907564296043
PLA2G1B,Phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36518,-0.0469696041762181,0.112210949429239,-0.266903065057527,0.172963856705091,0.675533135248434
PLA2G1B,Phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,36337,-0.0422720983460846,0.0444708498821087,-0.129434964115018,0.0448907674228484,0.341861270550953
PLA2G1B,Phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,36337,-0.0209986760941029,0.044071567400712,-0.107378948199499,0.0653815960112926,0.633755842322056
PLA2G1B,Phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,36337,0.0783720129433648,0.0441122028870654,-0.00808790471528338,0.164831930602013,0.075668195593644
PLA2G1B,Phospholipase A2,Diet and food preferences,X20603.Liking for apples,36337,0.0476897360817682,0.0455889761454508,-0.0416646571633153,0.137044129326852,0.295559338036256
PLA2G1B,Phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,36337,-0.0648871936115747,0.0451877367413321,-0.153455157624586,0.0236807704014362,0.151061277226809
PLA2G1B,Phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,36337,-0.176332391220608,0.0446453877742595,-0.263837351258156,-0.0888274311830594,7.90286441652308e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20606.Liking for avocados,36337,-0.144396107697714,0.0448457298027206,-0.232293738111046,-0.0564984772843812,0.00128836425273772
PLA2G1B,Phospholipase A2,Diet and food preferences,X20607.Liking for bacon,36337,-0.068748208509899,0.0450332264568718,-0.157013332365368,0.0195169153455698,0.126902158445618
PLA2G1B,Phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,36337,-0.0974319664397379,0.0448883942235143,-0.185413219117826,-0.00945071376164985,0.0299989868470052
PLA2G1B,Phospholipase A2,Diet and food preferences,X20609.Liking for bananas,36337,0.0516076520161642,0.0460698618468468,-0.0386892772036556,0.141904581235984,0.262664471386284
PLA2G1B,Phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36337,-0.104414037469597,0.0443631975551705,-0.191365904677732,-0.017462170261463,0.0186186665064869
PLA2G1B,Phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,36337,-0.085504489163539,0.0442532985447581,-0.172240954311265,0.00123197598418701,0.0533792068467057
PLA2G1B,Phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,36337,-0.119630419070038,0.0446191659086557,-0.207083984251003,-0.0321768538890728,0.00735396670978159
PLA2G1B,Phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,36337,-0.0921522778779303,0.0447217510286962,-0.179806909894175,-0.00449764586168575,0.0393802997060834
PLA2G1B,Phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,36337,0.0283509251702799,0.0447599012442404,-0.0593784812684313,0.116080331608991,0.526492715326046
PLA2G1B,Phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,36337,0.149516347348784,0.0448241636494552,0.0616609865958515,0.237371708101716,0.000855441906626061
PLA2G1B,Phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,36337,-0.193742283599917,0.044741235692033,-0.281435105556302,-0.106049461643532,1.50954098721027e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,36337,-0.155854028925572,0.045668365416888,-0.245364025142673,-0.066344032708472,0.000646719812960039
PLA2G1B,Phospholipase A2,Diet and food preferences,X20618.Liking for black olives,36337,-0.157863816380491,0.0450842364613041,-0.246228919844647,-0.0694987129163349,0.000465424824354899
PLA2G1B,Phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,36337,-0.148542813019026,0.0450118224944219,-0.236765985108093,-0.0603196409299594,0.000971300611064449
PLA2G1B,Phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,36337,-0.110093098102529,0.0442945844851995,-0.19691048369352,-0.0232757125115383,0.0129605862322316
PLA2G1B,Phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,36337,-0.0681185688415324,0.0447091677053013,-0.155748537543923,0.0195113998608581,0.127654771741111
PLA2G1B,Phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,36337,-0.0745722709019358,0.0445289682859581,-0.161849048742414,0.012704506938542,0.094038667333871
PLA2G1B,Phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,36337,-0.11663384509812,0.0464184620057661,-0.207614030629422,-0.0256536595668189,0.012004329774465
PLA2G1B,Phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,36337,0.0452186367656521,0.0444584734915915,-0.0419199712778672,0.132357244809171,0.309141171709134
PLA2G1B,Phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,36337,-0.0892564089921641,0.0446531582349982,-0.176776599132761,-0.00173621885156768,0.0456589596725047
PLA2G1B,Phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),36337,-0.0120601890365929,0.0440456021358264,-0.0983895692228126,0.0742691911496268,0.784237471006179
PLA2G1B,Phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,36337,-0.119968818787971,0.0446384769522357,-0.207460233614353,-0.0324774039615887,0.00721420371842937
PLA2G1B,Phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,36337,0.0212617560904447,0.0447654386071884,-0.0664785035796447,0.109002015760534,0.634830606992981
PLA2G1B,Phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,36337,-0.0469841556142178,0.0444939970723407,-0.134192389876006,0.0402240786475699,0.291019429516678
PLA2G1B,Phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,36337,-0.154084392101495,0.0449381486217315,-0.242163163400089,-0.0660056208029018,0.000609662490603962
PLA2G1B,Phospholipase A2,Diet and food preferences,X20631.Liking for cake,36337,0.191438749370778,0.0443902667650401,0.1044338265113,0.278443672230257,1.63497527895472e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,36337,0.108734054349733,0.0439118498983263,0.0226668285490131,0.194801280150452,0.0133023392984083
PLA2G1B,Phospholipase A2,Diet and food preferences,X20633.Liking for capers,36337,-0.192666805402084,0.0440931024539594,-0.279089286211844,-0.106244324592323,1.2626895216908e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,36337,-0.0890400540338448,0.0453068047372414,-0.177841391318838,-0.000238716748851536,0.0494218628991836
PLA2G1B,Phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,36337,0.107551203948253,0.0441725366613498,0.0209730320920072,0.194129375804498,0.0149244528044038
PLA2G1B,Phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,36337,0.0955810578730359,0.0441677344113847,0.00901229842672201,0.18214981731935,0.0304938118613015
PLA2G1B,Phospholipase A2,Diet and food preferences,X20637.Liking for cherries,36337,-0.0495963749113297,0.0471524627539622,-0.142015201909096,0.0428224520864362,0.292913178245875
PLA2G1B,Phospholipase A2,Diet and food preferences,X20638.Liking for chicken,36337,-0.0578216150895278,0.0463981927567125,-0.148762072892684,0.0331188427136288,0.21273041801479
PLA2G1B,Phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,36337,-0.153457123245754,0.044619140461944,-0.240910638551164,-0.0660036079403435,0.000586629876945785
PLA2G1B,Phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,36337,-0.0271148781348038,0.0446976876969768,-0.114722346020878,0.0604925897512706,0.544116980174791
PLA2G1B,Phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,36337,0.0196125614049307,0.0759687232074744,-0.129286136081719,0.168511258891581,0.796286040583506
PLA2G1B,Phospholipase A2,Diet and food preferences,X20642.Liking for cod,36337,-0.0843295475063519,0.0464307120346468,-0.17533374309426,0.00667464808155588,0.0693747539094405
PLA2G1B,Phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,36337,0.1200661357893,0.0481852006954665,0.0256231424261858,0.214509129152414,0.0127335891444862
PLA2G1B,Phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,36337,-0.150493777036632,0.045440708380171,-0.239557565461768,-0.0614299886114971,0.000931349946163962
PLA2G1B,Phospholipase A2,Diet and food preferences,X20645.Liking for coriander,36337,-0.122169800113181,0.0442299395624117,-0.208860481655508,-0.0354791185708544,0.00575688023858435
PLA2G1B,Phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,36337,0.118030915239342,0.0440864697660798,0.0316214344978254,0.204440395980858,0.00743970106176696
PLA2G1B,Phospholipase A2,Diet and food preferences,X20647.Liking for cream,36337,0.0421104746164908,0.0443551742312406,-0.0448256668767408,0.129046616109722,0.342453127563058
PLA2G1B,Phospholipase A2,Diet and food preferences,X20648.Liking for croissant,36337,-0.055457952153261,0.0439101048018221,-0.141521757564832,0.0306058532583104,0.20663463278176
PLA2G1B,Phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,36337,-0.0940214590736252,0.0450388887925861,-0.182297681107094,-0.00574523704015634,0.0368727831513878
PLA2G1B,Phospholipase A2,Diet and food preferences,X20650.Liking for curry,36337,-0.0862095946372703,0.0446262956669739,-0.173677134144539,0.00125794486999853,0.0534223210462897
PLA2G1B,Phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,36337,0.0394543065746253,0.0447054022323402,-0.0481682818007615,0.127076894950012,0.377514583963562
PLA2G1B,Phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,36337,-0.0116037899916354,0.0448394500484886,-0.0994891120866731,0.0762815321034024,0.795808375834281
PLA2G1B,Phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36337,-0.00702898315530548,0.0460771817091012,-0.0973402593051439,0.0832822929945329,0.878759027684724
PLA2G1B,Phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,36337,0.0219640040696693,0.0450656847374834,-0.0663647380157981,0.110292746155137,0.626005758937826
PLA2G1B,Phospholipase A2,Diet and food preferences,X20655.Liking for eggs,36337,0.00513081932365094,0.045915819728942,-0.0848641873450753,0.0951258259923772,0.911029500616438
PLA2G1B,Phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,36337,0.10973268940158,0.0440405585497937,0.0234131946439846,0.196052184159176,0.0127384511045177
PLA2G1B,Phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,36337,-0.0279910542401251,0.0442708162668689,-0.114761854123188,0.0587797456429379,0.52723153353268
PLA2G1B,Phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36337,-0.102354422238924,0.0455944454126113,-0.191719535247642,-0.0129893092302059,0.0248058391976401
PLA2G1B,Phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,36337,-0.0602320758488993,0.0443434659427358,-0.147145269096661,0.0266811173988629,0.174408986210004
PLA2G1B,Phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,36337,-0.130587508435112,0.0480754075929209,-0.224815307317237,-0.0363597095529865,0.00661740366734535
PLA2G1B,Phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,36337,-0.0447597324746776,0.0442658697858498,-0.131520837254943,0.0420013723055879,0.311975711325654
PLA2G1B,Phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,36337,-0.0440280316773139,0.0448564086511939,-0.131946592633654,0.0438905292790262,0.326363404249213
PLA2G1B,Phospholipase A2,Diet and food preferences,X20663.Liking for fruit,36337,0.00331163933481571,0.0504044631743513,-0.0954811084869129,0.102104387156544,0.94761746923413
PLA2G1B,Phospholipase A2,Diet and food preferences,X20664.Liking for garlic,36337,-0.135036511479834,0.0446397022033818,-0.222530327798462,-0.0475426951612052,0.00249492477897264
PLA2G1B,Phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,36337,-0.0840481692208709,0.0444481669611419,-0.171166576464709,0.00307023802296716,0.0586747803935808
PLA2G1B,Phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,36337,-0.105320744587275,0.0441017820046142,-0.191760237316319,-0.0188812518582314,0.0169602530799902
PLA2G1B,Phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,36337,-0.0711615435523629,0.0440422467657725,-0.157484347213277,0.0151612601085512,0.106191202816398
PLA2G1B,Phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,36337,0.0618003908836912,0.0449138811608301,-0.0262308161915358,0.149831597958918,0.168872474722077
PLA2G1B,Phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,36337,-0.060679404404139,0.0445789061329902,-0.1480540604248,0.0266952516165218,0.173503426695582
PLA2G1B,Phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,36337,-0.212420517363064,0.0443663412327703,-0.299378546179293,-0.125462488546834,1.71953350085537e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,36337,-0.0192271828540701,0.0440018038614183,-0.10547071842245,0.0670163527143097,0.662151033924675
PLA2G1B,Phospholipase A2,Diet and food preferences,X20672.Liking for green olives,36337,-0.126234189839838,0.0446932346143443,-0.213832929683953,-0.0386354499957232,0.00474919790920738
PLA2G1B,Phospholipase A2,Diet and food preferences,X20673.Liking for haddock,36337,-0.159485152480883,0.0459169670160076,-0.249482407832258,-0.0694878971295083,0.00051707874873214
PLA2G1B,Phospholipase A2,Diet and food preferences,X20674.Liking for ham,36337,-0.0196537502740331,0.0448080593935378,-0.107477546685367,0.068170046137301,0.66094954991589
PLA2G1B,Phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,36337,-0.0340466136411074,0.0452690983280622,-0.122774046364109,0.0546808190818945,0.452019392276475
PLA2G1B,Phospholipase A2,Diet and food preferences,X20676.Liking for herring,36337,-0.0906811989072356,0.0444913292121407,-0.177884204163031,-0.00347819365143992,0.041569051820323
PLA2G1B,Phospholipase A2,Diet and food preferences,X20677.Liking for honey,36337,-0.029771624826904,0.0445370312423421,-0.117064206061895,0.0575209564080866,0.503855889983868
PLA2G1B,Phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36337,-0.135085306929902,0.0442720701986965,-0.221858564519347,-0.0483120493404566,0.00228725748544422
PLA2G1B,Phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,36337,0.0990123248992723,0.0452260388239692,0.0103692888042927,0.187655360994252,0.0286090033815864
PLA2G1B,Phospholipase A2,Diet and food preferences,X20680.Liking for jam,36337,0.0940876415529035,0.044438961981531,0.0069872760691027,0.181188007036704,0.034274579748639
PLA2G1B,Phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,36337,0.00533977222590506,0.044617986458363,-0.0821114812324863,0.0927910256842965,0.904741938587159
PLA2G1B,Phospholipase A2,Diet and food preferences,X20682.Liking for lager,36337,-0.128632012476326,0.0446105874777363,-0.216068763932689,-0.0411952610199629,0.00394532190631946
PLA2G1B,Phospholipase A2,Diet and food preferences,X20683.Liking for lamb,36337,-0.0911407397074414,0.0446561031047849,-0.17866670179282,-0.00361477762206286,0.0412928239039659
PLA2G1B,Phospholipase A2,Diet and food preferences,X20684.Liking for lemons,36337,-0.127437101875287,0.0448032281935011,-0.215251429134549,-0.039622774616025,0.00446255414157601
PLA2G1B,Phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,36337,-0.0303878118908956,0.0450034268196115,-0.118594528457334,0.0578189046755429,0.499549444342819
PLA2G1B,Phospholipase A2,Diet and food preferences,X20686.Liking for liver,36337,-0.14452874419139,0.0439860728151791,-0.230741446909141,-0.0583160414736391,0.00102189965067185
PLA2G1B,Phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,36337,-0.0617045681000207,0.0446750915254729,-0.149267747489948,0.0258586112899061,0.167265332878131
PLA2G1B,Phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,36337,0.0779454651052996,0.044292493721419,-0.0088678225886816,0.164758752799281,0.0784863586019785
PLA2G1B,Phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,36337,-0.0301666098612956,0.0443695076955045,-0.117130844944484,0.0567976252218933,0.496592959799056
PLA2G1B,Phospholipase A2,Diet and food preferences,X20690.Liking for melon,36337,-0.00115480724700468,0.0459725441920029,-0.0912609938633304,0.0889513793693211,0.9799603502376
PLA2G1B,Phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,36337,0.108779648245048,0.0442294954396302,0.0220898371833726,0.195469459306723,0.0139390785283728
PLA2G1B,Phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,36337,-0.0295514996025911,0.0456989835338987,-0.119121507329033,0.0600185081238504,0.517875725053394
PLA2G1B,Phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,36337,0.0331129770283521,0.0449987491164705,-0.0550845712399301,0.121310525296634,0.461837424029981
PLA2G1B,Phospholipase A2,Diet and food preferences,X20695.Liking for oranges,36337,0.00461692818585231,0.0459602481983782,-0.0854651582829689,0.0946990146546735,0.919986077283541
PLA2G1B,Phospholipase A2,Diet and food preferences,X20696.Liking for pasta,36337,-0.037019100576888,0.0452426340428731,-0.125694663300919,0.0516564621471433,0.413250418980047
PLA2G1B,Phospholipase A2,Diet and food preferences,X20697.Liking for pears,36337,-0.0201757072130527,0.0456128864163724,-0.109576964589143,0.0692255501630371,0.658267654316173
PLA2G1B,Phospholipase A2,Diet and food preferences,X20698.Liking for pizza,36337,0.0913016047027707,0.0448485667670355,0.00339841383938123,0.17920479556616,0.0418097958094439
PLA2G1B,Phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,36337,-0.0335840300980745,0.0448216433520653,-0.121434451068122,0.0542663908719734,0.45371223504327
PLA2G1B,Phospholipase A2,Diet and food preferences,X20700.Liking for plums,36337,0.00798637858550178,0.0456180732183314,-0.0814250449224277,0.0973978020934313,0.861029211343599
PLA2G1B,Phospholipase A2,Diet and food preferences,X20701.Liking for pollock,36337,-0.126988663354217,0.0446256639094184,-0.214454964616677,-0.039522362091757,0.00444483428922725
PLA2G1B,Phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,36337,-0.0201195376116375,0.0441972905844705,-0.1067462271572,0.0665071519339247,0.648964061765549
PLA2G1B,Phospholipase A2,Diet and food preferences,X20703.Liking for porridge,36337,0.0520032175792483,0.0456431696512094,-0.0374573949371222,0.141463830095619,0.254598449379968
PLA2G1B,Phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,36337,0.0188510961909247,0.0446286843994119,-0.0686211252319226,0.106323317613772,0.672746790346554
PLA2G1B,Phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,36337,-0.0123124982334308,0.0453583144748041,-0.101214794604047,0.0765897981371852,0.786053078941107
PLA2G1B,Phospholipase A2,Diet and food preferences,X20706.Liking for prawns,36337,-0.150531604700839,0.0454227937347767,-0.239560280421002,-0.0615029289806769,0.000924265354218016
PLA2G1B,Phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,36337,-0.0440332825612951,0.0448560479926293,-0.131951136626849,0.0438845715042585,0.326301825985298
PLA2G1B,Phospholipase A2,Diet and food preferences,X20708.Liking for red meat,36337,-0.108986101130553,0.0444291357772032,-0.196067207253872,-0.0219049950072351,0.0141895284130285
PLA2G1B,Phospholipase A2,Diet and food preferences,X20709.Liking for red wine,36337,-0.251445562787933,0.0451695159835637,-0.339977814115718,-0.162913311460148,2.69028193030627e-08
PLA2G1B,Phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36337,0.109845363434013,0.0461522205803669,0.0193870110964938,0.200303715771532,0.0173356231160449
PLA2G1B,Phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,36337,-0.0433795959979266,0.046370911052256,-0.134266581660348,0.0475073896644953,0.349566694459273
PLA2G1B,Phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,36337,-0.0685796165745137,0.0444296767452144,-0.155661782995134,0.0185025498461065,0.12274070884127
PLA2G1B,Phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,36337,-0.0503442352448213,0.0449464765761511,-0.138439329334077,0.0377508588444348,0.26271182641157
PLA2G1B,Phospholipase A2,Diet and food preferences,X20714.Liking for salami,36337,-0.103078504680716,0.0443314327672655,-0.189968112904556,-0.0161888964568754,0.0200903123999203
PLA2G1B,Phospholipase A2,Diet and food preferences,X20715.Liking for salmon,36337,-0.125529574971655,0.0468711987775951,-0.217397124575741,-0.0336620253675683,0.00741927148420055
PLA2G1B,Phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,36337,-0.0515097717705104,0.0442378302987444,-0.138215919156049,0.0351963756150287,0.244307823286839
PLA2G1B,Phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,36337,-0.0740149719456945,0.0439771449639219,-0.160210176074981,0.0121802321835925,0.0924125221923761
PLA2G1B,Phospholipase A2,Diet and food preferences,X20718.Liking for sardines,36337,-0.050489782117501,0.0445784859029582,-0.137863614487299,0.0368840502522972,0.257418552097295
PLA2G1B,Phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),36337,-0.0156138109785988,0.044291963772657,-0.102426059973006,0.0711984380158089,0.724458601959821
PLA2G1B,Phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,36337,-0.0487716102757677,0.044696741464627,-0.136377223546437,0.0388340029949013,0.275236247009685
PLA2G1B,Phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36337,-0.188838529429752,0.0446052108874966,-0.276264742769246,-0.101412316090259,2.32913967595558e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,36337,0.0160686500998285,0.0441218791138762,-0.0704102329633689,0.102547533163026,0.7157285695829
PLA2G1B,Phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,36337,-0.117055879653116,0.0447735127591189,-0.204811964660989,-0.0292997946452427,0.00895721792321755
PLA2G1B,Phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,36337,-0.00552994998440271,0.0446241557996669,-0.0929932953517498,0.0819333953829444,0.901379897711254
PLA2G1B,Phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,36337,-0.140673966937375,0.0445071305108928,-0.227907942738725,-0.053439991136025,0.00158045583415851
PLA2G1B,Phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,36337,0.0076580392011667,0.0446042880611314,-0.0797663653986509,0.0950824438009843,0.863687369301143
PLA2G1B,Phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,36337,-0.147856118655284,0.0444006998702513,-0.234881490400976,-0.0608307469095911,0.000872740558565413
PLA2G1B,Phospholipase A2,Diet and food preferences,X20728.Liking for spinach,36337,-0.119067791129678,0.0453172905465051,-0.207889680600827,-0.0302459016585276,0.00862178491653594
PLA2G1B,Phospholipase A2,Diet and food preferences,X20729.Liking for spirits,36337,-0.201522454562904,0.0448479466132879,-0.289424429924948,-0.11362047920086,7.11803441522684e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,36337,0.0319344636680906,0.0486974648204742,-0.0635125673800387,0.12738149471622,0.511991588635346
PLA2G1B,Phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36337,0.0559870427700814,0.0457252389816417,-0.0336344256339364,0.145608511174099,0.220833058386967
PLA2G1B,Phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,36337,0.127665593292617,0.0439781852331694,0.0414683502356048,0.213862836349629,0.00370822163571338
PLA2G1B,Phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,36337,-0.033435847403904,0.0447991837431843,-0.121242247540545,0.0543705527327372,0.455480923318746
PLA2G1B,Phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,36337,0.135382387515107,0.0545771705815987,0.0284111331751733,0.24235364185504,0.0131402079025404
PLA2G1B,Phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,36337,-0.0447953451864449,0.0466623895738307,-0.136253628751153,0.0466629383782632,0.337093668271001
PLA2G1B,Phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,36337,-0.0160357617880189,0.044439969910176,-0.103138102811964,0.0710665792359261,0.718229018756718
PLA2G1B,Phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,36337,0.0101447951138525,0.0445271303905214,-0.0771283804515693,0.0974179706792744,0.819781807290242
PLA2G1B,Phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),36337,-0.0645041154511365,0.0443144492848305,-0.151360436049404,0.0223522051471313,0.145547211012015
PLA2G1B,Phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,36337,-0.0749997954374383,0.0485193817472234,-0.170097783661996,0.0200981927871196,0.122204526936578
PLA2G1B,Phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,36337,-0.117303647658578,0.0444238779806016,-0.204374448500558,-0.0302328468165994,0.00829508986688616
PLA2G1B,Phospholipase A2,Diet and food preferences,X20741.Liking for watching television,36337,0.00688042999863736,0.0454732222487657,-0.0822470856089433,0.0960079456062181,0.879737597550786
PLA2G1B,Phospholipase A2,Diet and food preferences,X20742.Liking for whisky,36337,-0.161844579054465,0.0455050679900157,-0.251034512314896,-0.072654645794034,0.000378082733446349
PLA2G1B,Phospholipase A2,Diet and food preferences,X20743.Liking for white bread,36337,0.0769310121257641,0.0436950808326166,-0.00871134630616435,0.162573370557693,0.0783433388028297
PLA2G1B,Phospholipase A2,Diet and food preferences,X20744.Liking for white rice,36337,-0.0536687277729662,0.0445759539915777,-0.141037597596459,0.0337001420505261,0.228635774565593
PLA2G1B,Phospholipase A2,Diet and food preferences,X20745.Liking for white wine,36337,-0.138296571535788,0.0444176282475744,-0.225355122901034,-0.0512380201705419,0.00185582016270624
PLA2G1B,Phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36337,0.00418311095890949,0.0456376919173265,-0.0852667651990504,0.0936329871168694,0.926971446767653
PLA2G1B,Phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,36337,0.0265177700820071,0.0440168000231783,-0.0597551579634224,0.112790698127437,0.54689606826076
PLA2G1B,Phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,36337,-0.0254547277157425,0.0465557075765654,-0.116703914565811,0.0657944591343257,0.584561774838012
PLA2G1B,Phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,36337,0.0193327467682389,0.0446371850952593,-0.0681561360184693,0.106821629554947,0.664949001246982
PLA2G1B,Phospholipase A2,Physical measures,X21001.Body mass index (BMI),52500,-0.0976286029085199,0.0156004031419292,-0.128205393066701,-0.0670518127503388,3.96528020327449e-10
PLA2G1B,Phospholipase A2,Physical measures,X21002.Weight,52519,-0.074818277452726,0.00837588168057924,-0.0912350055466613,-0.0584015493587907,4.46244977560197e-19
PLA2G1B,Phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,37170,-0.0131585520839892,0.00559427191581938,-0.0241233250389951,-0.00219377912898318,0.0186895512761743
PLA2G1B,Phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36151,-0.0333673989609999,0.0480191406390068,-0.127484914613453,0.0607501166914534,0.48715557691602
PLA2G1B,Phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36168,0.0925286980034073,0.0485436625517297,-0.00261688059798292,0.187674276604798,0.0566793261789446
PLA2G1B,Phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36170,-0.0333158514178323,0.0482476005696837,-0.127881148534412,0.0612494456987477,0.489891285186556
PLA2G1B,Phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,36124,-0.0497363081549333,0.0443637183443075,-0.136689196109776,0.0372165797999094,0.262282819228492
PLA2G1B,Phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36106,-0.0277136020262816,0.0484214289301992,-0.122619602729472,0.0671923986769089,0.567109155804572
PLA2G1B,Phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,36124,-0.0130022515840818,0.047402013657771,-0.105910198353313,0.0799056951851493,0.783864219092641
PLA2G1B,Phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,36056,0.0588703111136152,0.0478433501222712,-0.0349026551260363,0.152643277353267,0.218559395546468
PLA2G1B,Phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,36088,-0.0248440891503285,0.0541538655705793,-0.130985665668664,0.0812974873680068,0.646414877263679
PLA2G1B,Phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36174,-0.0114023300794802,0.0483127142172128,-0.106095249945217,0.0832905897862568,0.813431090852754
PLA2G1B,Phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36169,0.0327623188350562,0.0484371102562578,-0.0621744172672091,0.127699054937321,0.498816257821757
PLA2G1B,Phospholipase A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32854,0.0390012785807352,0.0872024932233254,-0.131915608136982,0.209918165298453,0.654721339289108
PLA2G1B,Phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36172,-0.00534794667325973,0.0557380570041057,-0.114594538401307,0.103898645054787,0.923564747519385
PLA2G1B,Phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36171,0.055296191124602,0.0720897295144134,-0.0859996787236481,0.196592060972852,0.443079691651634
PLA2G1B,Phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36169,0.0354670709405508,0.0556199393040073,-0.0735480100953034,0.144482151976405,0.523710573565399
PLA2G1B,Phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36169,-0.25994054329188,0.140408643665594,-0.535141484876445,0.0152603982926848,0.0641665828535284
PLA2G1B,Phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36175,0.0607969330494642,0.0569771930841938,-0.0508783653955556,0.172472231494484,0.285990765516076
PLA2G1B,Phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36171,-0.0666944564663917,0.0527309320394403,-0.170047083263695,0.0366581703309113,0.205982741366073
PLA2G1B,Phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,36012,-0.0270369065688305,0.0505971665293704,-0.126207352966397,0.0721335398287356,0.593112586543117
PLA2G1B,Phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36165,0.00512221716690618,0.0487882740902317,-0.0905028000499479,0.10074723438376,0.916387801208882
PLA2G1B,Phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36171,-0.0902268554571491,0.0778715868184841,-0.242855165621378,0.0624014547070796,0.246633611525173
PLA2G1B,Phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36176,-0.00479923827435623,0.0488393963389353,-0.100524455098669,0.090925978549957,0.921724121863795
PLA2G1B,Phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36175,-0.0288278407880894,0.048540511985317,-0.123967244279311,0.0663115627031319,0.552603333479506
PLA2G1B,Phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),52470,0.0353382631990149,0.0244688032497474,-0.01262059117049,0.0832971175685199,0.148691387416157
PLA2G1B,Phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,48630,0.0121886898202002,0.00379537524924506,0.00474975433167992,0.0196276253087205,0.0013227797764361
PLA2G1B,Phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,47417,-0.117762300454509,0.0282807746204214,-0.173192618710535,-0.0623319821984827,3.14102093604325e-05
PLA2G1B,Phospholipase A2,Physical activities,X22032.IPAQ activity group,47406,-0.0400847339008218,0.0279182097639411,-0.0948044250381464,0.0146349572365027,0.151078797695372
PLA2G1B,Phospholipase A2,Physical activities,X22033.Summed days activity,47924,-0.0115022191026783,0.00376980358688662,-0.0188910341329761,-0.00411340407238054,0.0022828901965116
PLA2G1B,Phospholipase A2,Physical activities,X22034.Summed minutes activity,47406,-0.00529301638423083,0.00374256105421351,-0.0126284360504893,0.00204240328202765,0.157297810460218
PLA2G1B,Phospholipase A2,Physical activities,X22037.MET minutes per week for walking,46409,-0.00543318232520563,0.00399587185895357,-0.0132650911687546,0.00239872651834336,0.173943053680777
PLA2G1B,Phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,47406,-0.0119470885257021,0.00365145422932168,-0.0191039388151726,-0.00479023823623159,0.00107036940856651
PLA2G1B,Phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,47406,-0.0439653368464035,0.0278098575386812,-0.0984726576222186,0.0105419839294116,0.113912243067601
PLA2G1B,Phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,46409,-0.00897201070926697,0.00387585274080261,-0.0165686820812401,-0.00137533933729385,0.0206329445996031
PLA2G1B,Phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,50606,-0.00346065344131705,0.00315821398632202,-0.00965075285450822,0.00272944597187412,0.273194910725269
PLA2G1B,Phospholipase A2,Working and living environment,X22501.Year ended full time education,34198,0.0356883583703256,0.0148296813092919,0.00662218300411353,0.0647545337365376,0.0161400479074596
PLA2G1B,Phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,34166,0.157921183576304,0.117457634957164,-0.072295780939737,0.388138148092344,0.178849784105107
PLA2G1B,Phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,51274,-0.172889275659653,0.0904069895264641,-0.350086975131523,0.00430842381221691,0.0558449951126586
PLA2G1B,Phospholipase A2,Physical measures,X23098.Weight,52026,-0.0751515502589235,0.00844111862467055,-0.0916961427632778,-0.0586069577545693,5.83024912396078e-19
PLA2G1B,Phospholipase A2,Physical measures,X23099.Body fat percentage,52018,-0.0250301287580537,0.00804310535345057,-0.0407946152508168,-0.00926564226529061,0.00186055012280229
PLA2G1B,Phospholipase A2,Physical measures,X23100.Whole body fat mass,52002,-0.0494531439211852,0.00792514662151382,-0.0649864312993523,-0.0339198565430182,4.45188457850562e-10
PLA2G1B,Phospholipase A2,Physical measures,X23101.Whole body fat-free mass,52025,-0.0400178804567638,0.00688364291440314,-0.053509820568994,-0.0265259403445337,6.20040479559316e-09
PLA2G1B,Phospholipase A2,Physical measures,X23102.Whole body water mass,52026,-0.0405639286767248,0.00690514729583938,-0.05409801737657,-0.0270298399768796,4.30138214828326e-09
PLA2G1B,Phospholipase A2,Physical measures,X23104.Body mass index (BMI),52026,-0.0878146357847212,0.0155902128653232,-0.118371453000755,-0.0572578185686878,1.79521102896609e-08
PLA2G1B,Phospholipase A2,Physical measures,X23105.Basal metabolic rate,52026,-0.0484628751701805,0.00735026489394259,-0.062869394362308,-0.034056355978053,4.39401747727872e-11
PLA2G1B,Phospholipase A2,Physical measures,X23106.Impedance of whole body,52023,0.00111000806491312,0.00561851326899805,-0.00990227794232306,0.0121222940721493,0.84338906122616
PLA2G1B,Phospholipase A2,Physical measures,X23107.Impedance of leg (right),52026,0.00157893421416317,0.00453792798093057,-0.00731540462846074,0.0104732730567871,0.727887201933588
PLA2G1B,Phospholipase A2,Physical measures,X23108.Impedance of leg (left),52026,0.000725661715261166,0.00450536357447143,-0.00810485089070284,0.00955617432122517,0.872042699321956
PLA2G1B,Phospholipase A2,Physical measures,X23109.Impedance of arm (right),52023,0.00416983825584587,0.0055538362202336,-0.00671568073581198,0.0150553572475037,0.452778814896332
PLA2G1B,Phospholipase A2,Physical measures,X23110.Impedance of arm (left),52026,0.00203072173887574,0.00557903470300915,-0.0089041862790222,0.0129656297567737,0.715867656359295
PLA2G1B,Phospholipase A2,Physical measures,X23111.Leg fat percentage (right),52026,-0.016637557985528,0.00944992518201987,-0.0351594113422869,0.00188429537123096,0.0783191615526338
PLA2G1B,Phospholipase A2,Physical measures,X23112.Leg fat mass (right),52026,-0.0465452201902972,0.010350052099722,-0.0668313223057524,-0.0262591180748421,6.92256781320439e-06
PLA2G1B,Phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),52025,-0.0398529145855469,0.00699991745698068,-0.0535727528012291,-0.0261330763698648,1.26105964794748e-08
PLA2G1B,Phospholipase A2,Physical measures,X23114.Leg predicted mass (right),52025,-0.0405149982375033,0.0070428007274881,-0.0543188876633799,-0.0267111088116266,8.89605347873399e-09
PLA2G1B,Phospholipase A2,Physical measures,X23115.Leg fat percentage (left),52023,-0.0234467243603579,0.00991820435161041,-0.0428864048895144,-0.00400704383120154,0.0180866972847928
PLA2G1B,Phospholipase A2,Physical measures,X23116.Leg fat mass (left),52023,-0.0557436125062425,0.010828869542188,-0.0769681968089309,-0.0345190282035542,2.65906541606772e-07
PLA2G1B,Phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),52022,-0.0420164430701356,0.00736378169747363,-0.0564494551971839,-0.0275834309430873,1.17214482045364e-08
PLA2G1B,Phospholipase A2,Physical measures,X23118.Leg predicted mass (left),52022,-0.0417110876596284,0.00741031740005352,-0.0562353097637333,-0.0271868655555235,1.83612777423358e-08
PLA2G1B,Phospholipase A2,Physical measures,X23119.Arm fat percentage (right),52022,-0.0199374573706412,0.00908801651927842,-0.0377499697484269,-0.00212494499285547,0.0282585158128588
PLA2G1B,Phospholipase A2,Physical measures,X23120.Arm fat mass (right),52020,-0.0584336267032477,0.00906279568768398,-0.0761967062511083,-0.0406705471553871,1.15879172428576e-10
PLA2G1B,Phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),52021,-0.0388882878223222,0.00704020128559111,-0.0526870823420808,-0.0250894933025636,3.35464811842055e-08
PLA2G1B,Phospholipase A2,Physical measures,X23122.Arm predicted mass (right),52021,-0.0386634686716449,0.00705706105330225,-0.0524953083361173,-0.0248316290071725,4.33005653461178e-08
PLA2G1B,Phospholipase A2,Physical measures,X23123.Arm fat percentage (left),52020,-0.0227851897402872,0.00931314413135988,-0.0410389522377525,-0.00453142724282178,0.0144300665910837
PLA2G1B,Phospholipase A2,Physical measures,X23124.Arm fat mass (left),52020,-0.0652000730167948,0.00907387723785441,-0.0829848724029894,-0.0474152736306001,6.90349246092811e-13
PLA2G1B,Phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),52020,-0.0457383869474513,0.00718441642915119,-0.0598198431485877,-0.031656930746315,1.97284574301949e-10
PLA2G1B,Phospholipase A2,Physical measures,X23126.Arm predicted mass (left),52018,-0.0431159220630924,0.00718743867430478,-0.0572033018647298,-0.029028542261455,2.01789400193794e-09
PLA2G1B,Phospholipase A2,Physical measures,X23127.Trunk fat percentage,52017,-0.0195862692797773,0.00575604855475976,-0.0308681244471064,-0.00830441411244813,0.000668311280467924
PLA2G1B,Phospholipase A2,Physical measures,X23128.Trunk fat mass,52017,-0.0391568593037317,0.00642997843233243,-0.0517596170311033,-0.0265541015763601,1.1490535911088e-09
PLA2G1B,Phospholipase A2,Physical measures,X23129.Trunk fat-free mass,52016,-0.034066383185929,0.00621234952333513,-0.0462425882516659,-0.0218901781201922,4.21043404734783e-08
PLA2G1B,Phospholipase A2,Physical measures,X23130.Trunk predicted mass,52013,-0.0344958255559089,0.00623065822685371,-0.0467079156805422,-0.0222837354312757,3.1203347362529e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,42782,-0.027846473731179,0.0045051565597625,-0.0366765805883135,-0.0190163668740445,6.55088982630624e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42782,-0.0189192141593296,0.00437558817020926,-0.0274953669729397,-0.0103430613457195,1.54449640364944e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42782,-0.0195316605343475,0.00436889094139543,-0.0280946867794826,-0.0109686342892125,7.86238741966486e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,42782,-0.0107992315684784,0.00444358044588822,-0.0195086492424194,-0.00208981389453753,0.0150992056789469
PLA2G1B,Phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,42782,-0.0163203084516751,0.00437165612274399,-0.0248887544522533,-0.00775186245109689,0.000189826626830744
PLA2G1B,Phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,42782,-0.0176485263679851,0.00439298110292516,-0.0262587693297184,-0.00903828340625174,5.91512786931687e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,42782,-0.0419007199065193,0.00502333835021818,-0.0517464630729469,-0.0320549767400916,8.05637279978843e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,42782,-0.0199197357154092,0.00479724289715381,-0.0293223317938307,-0.0105171396369877,3.31116416369749e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,42782,-0.0170558844512558,0.00477987861614788,-0.0264244465389057,-0.00768732236360598,0.000360587441557173
PLA2G1B,Phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,42782,-0.0223969398641127,0.00475721599377199,-0.0317210832119058,-0.0130727965163196,2.52639108163741e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,42782,-0.030563727683612,0.00469657352086593,-0.0397690117845092,-0.0213584435827148,7.90047170499559e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42782,-0.0461509617546755,0.00465892698224305,-0.0552824586398719,-0.0370194648694792,4.69664276943237e-23
PLA2G1B,Phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,42782,-0.0128780719759188,0.00458481988437142,-0.0218643189492868,-0.00389182500255082,0.00497897539612312
PLA2G1B,Phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,42782,-0.01735635093949,0.00436661534224509,-0.0259149170102903,-0.00879778486868959,7.08075542952971e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,42782,-0.0557114562260049,0.00498110137111691,-0.065474414913394,-0.0459484975386158,6.49003261459975e-29
PLA2G1B,Phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,42782,-0.0290341994173513,0.00452687833953014,-0.0379068809628304,-0.0201615178718722,1.4669718248319e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42782,-0.00956213561672012,0.00439189837774188,-0.0181702564370942,-0.000954014796346027,0.0294811936530925
PLA2G1B,Phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42782,-0.0183457750859909,0.00439890813857007,-0.0269676350375882,-0.00972391513439355,3.05779500123167e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42782,-0.0391012024353013,0.00499913198999224,-0.0488995011356861,-0.0293029037349165,5.59880590534757e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,42782,-0.0244977576840527,0.00445580618631423,-0.0332311378092286,-0.0157643775588768,3.91185458709624e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,42782,-0.0120756291509734,0.00453260794763203,-0.0209595407283322,-0.0031917175736146,0.00772700985463442
PLA2G1B,Phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,42782,-0.0150653038010925,0.00439905842053677,-0.0236874583053446,-0.00644314929684048,0.00061737529998332
PLA2G1B,Phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,42782,-0.0480581007712397,0.00506898080879342,-0.0579933031564748,-0.0381228983860046,2.93493792760433e-21
PLA2G1B,Phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42782,-0.0349425324230421,0.00449440661114951,-0.0437515693808951,-0.026133495465189,8.10658534689403e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,42782,-0.0152033520612847,0.00464556026779422,-0.0243086501861614,-0.00609805393640804,0.00106805464013908
PLA2G1B,Phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,42782,-0.0184066542253454,0.00438957332362188,-0.0270102179396443,-0.00980309051104653,2.76707765020539e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,42782,-0.0515241763146087,0.00501112217367472,-0.0613459757750111,-0.0417023768542062,1.0467125001489e-24
PLA2G1B,Phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42782,-0.0511668497727221,0.00472879059784098,-0.0604352793444904,-0.0418984202009537,3.56082163491448e-27
PLA2G1B,Phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,42782,-0.0114630280175199,0.00452402911085107,-0.020330125074788,-0.00259593096025179,0.0112941442785278
PLA2G1B,Phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,42782,-0.0070549807329156,0.00435605300464871,-0.0155928446220271,0.00148288315619588,0.105345517748183
PLA2G1B,Phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,42782,-0.0518109685008779,0.00473632275971855,-0.0610941611099263,-0.0425277758918295,9.78367202832346e-28
PLA2G1B,Phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42782,-0.00864129221113551,0.00486388188841332,-0.0181745007124256,0.000891916290154589,0.0756523939883034
PLA2G1B,Phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,42782,0.0128590835142611,0.00462689904827833,0.00379036137963559,0.0219278056488866,0.00545676187625037
PLA2G1B,Phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,42782,-0.0193033920487197,0.0052043323600454,-0.0295038834744087,-0.00910290062303074,0.000208825130884078
PLA2G1B,Phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,42770,-0.0541151106135201,0.00474292106490131,-0.0634112359007267,-0.0448189853263136,5.1266595995747e-30
PLA2G1B,Phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42770,0.00474870720578198,0.00498658656027323,-0.00502500245235354,0.0145224168639175,0.340963761383564
PLA2G1B,Phospholipase A2,NMR metabolomics,X23436.Total Cholines,42770,-0.0492593499250737,0.00475249481055375,-0.058574239753759,-0.0399444600963883,4.43977911384592e-25
PLA2G1B,Phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,42770,-0.0563071182963964,0.00478245400289711,-0.0656807281420747,-0.0469335084507181,7.61895963738427e-32
PLA2G1B,Phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,42770,-0.0294544193304569,0.00467808000646345,-0.0386234561431252,-0.0202853825177885,3.14296442752629e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,42782,-0.0101787579539449,0.00435362522450164,-0.0187118633939681,-0.00164565251392165,0.019401891442016
PLA2G1B,Phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,42782,-0.0535861893702426,0.004889031210913,-0.0631686905436321,-0.0440036881968531,7.73916221969144e-28
PLA2G1B,Phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42782,0.016268067423266,0.00445775958672965,0.00753085863327584,0.0250052762132561,0.000263856909520701
PLA2G1B,Phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,42770,-0.034134945774812,0.00463014313711413,-0.0432100263235557,-0.0250598652260683,1.77369831785817e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,42770,0.015802275077428,0.00471738572235624,0.00655619906160977,0.0250483510932462,0.000810916633302407
PLA2G1B,Phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,42770,-0.0219316986085501,0.00467448441978207,-0.031093688071323,-0.0127697091457773,2.73467810393019e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,42770,-0.0197754754599927,0.00457161177811306,-0.0287358345450943,-0.0108151163748911,1.53126048969035e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42770,-0.0222738655653918,0.00463188754724179,-0.0313523651579857,-0.0131953659727979,1.53460946934005e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42770,-0.0238925040146703,0.00474873518312417,-0.0332000249735937,-0.0145849830557469,4.93288858815082e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,42770,-0.0476680129259278,0.00462158005703932,-0.0567263098377249,-0.0386097160141307,7.50616067960604e-25
PLA2G1B,Phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,42770,-0.00907544356031607,0.00448049617176614,-0.0178572160569777,-0.000293671063654435,0.0428310262066967
PLA2G1B,Phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,42770,-0.0151240597812722,0.00467021589458042,-0.0242776829346498,-0.00597043662789461,0.00120488061695225
PLA2G1B,Phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42770,-0.00616369549262744,0.00462878435065465,-0.0152361128199106,0.00290872183465568,0.183013577852943
PLA2G1B,Phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42770,0.0397700786421859,0.00496088908669554,0.0300467360322627,0.0494934212521092,1.17432379741986e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42770,0.0378834735738439,0.00490165561886988,0.028276228560859,0.0474907185868289,1.16250820086811e-14
PLA2G1B,Phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42770,0.00403239374374016,0.00497548711994892,-0.00571956101135972,0.01378434849884,0.417694618414342
PLA2G1B,Phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42770,-0.0679740332692296,0.00447651930842845,-0.0767480111137493,-0.0592000554247098,1.1880342487893e-51
PLA2G1B,Phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42770,0.0404332197063011,0.00476686397114377,0.0310901663228593,0.0497762730897429,2.43753392469796e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42770,0.00520764232550347,0.00461870040834298,-0.00384501047484876,0.0142602951258557,0.25954579613853
PLA2G1B,Phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42770,0.0157663688187556,0.00498477945815367,0.00599620108077439,0.0255365365567368,0.00156549016360651
PLA2G1B,Phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42770,0.0154617789264648,0.00457691537861068,0.00649102478438784,0.0244325330685417,0.000731645346300985
PLA2G1B,Phospholipase A2,NMR metabolomics,X23460.Alanine,42776,-0.0199811595452335,0.00450897980884901,-0.0288187599705776,-0.0111435591198895,9.4349969714497e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23461.Glutamine,42736,-0.0111885334404772,0.00452548554007521,-0.0200584850990246,-0.00231858178192976,0.0134354165476009
PLA2G1B,Phospholipase A2,NMR metabolomics,X23462.Glycine,42766,0.0301003330168142,0.00479956325626309,0.0206931890345386,0.0395074769990899,3.6849237736775e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23463.Histidine,42762,0.00196402981009091,0.00445549137958456,-0.00676873329389483,0.0106967929140767,0.659356820178425
PLA2G1B,Phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42772,-0.0255294424996852,0.00470329648666817,-0.0347479036135548,-0.0163109813858156,5.79713442431702e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23465.Isoleucine,42778,-0.0211548295629376,0.00458361010968745,-0.030138705377925,-0.0121709537479502,3.96081931485451e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23466.Leucine,42778,-0.0204588804824513,0.00464071279707053,-0.0295546775647096,-0.0113630834001931,1.0485695684028e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23467.Valine,42772,-0.0284403922547116,0.00474725928690221,-0.03774502045704,-0.0191357640523833,2.13951556852228e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23468.Phenylalanine,42774,0.00384573201674248,0.00450860381548675,-0.00499113146161155,0.0126825954950965,0.393687513574843
PLA2G1B,Phospholipase A2,NMR metabolomics,X23469.Tyrosine,42765,-0.0366825609352284,0.00456580548840945,-0.0456315396925109,-0.0277335821779459,1.01926927996836e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23470.Glucose,42754,-0.0478061025423269,0.00443655457525021,-0.0565017495098173,-0.0391104555748365,5.77749843020583e-27
PLA2G1B,Phospholipase A2,NMR metabolomics,X23471.Lactate,42756,-0.00711613036478126,0.00446138979951664,-0.0158604543718339,0.00162819364227136,0.110724829361856
PLA2G1B,Phospholipase A2,NMR metabolomics,X23472.Pyruvate,42739,-0.00610745191025594,0.00452110555059657,-0.0149688187894252,0.00275391496891334,0.176757798664527
PLA2G1B,Phospholipase A2,NMR metabolomics,X23473.Citrate,42779,0.0180305118975137,0.00451906449502211,0.00917314548727032,0.026887878307757,6.64544163258116e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,42554,0.00444412522748149,0.00475041136055983,-0.00486668103921577,0.0137549314941788,0.349535079224337
PLA2G1B,Phospholipase A2,NMR metabolomics,X23475.Acetate,42770,-0.00017406652839842,0.00443854307648329,-0.00887361095830567,0.00852547790150883,0.96871792351976
PLA2G1B,Phospholipase A2,NMR metabolomics,X23476.Acetoacetate,42780,-0.0178314347232811,0.00456653008135712,-0.0267818336827411,-0.00888103576382117,9.4755218021062e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23477.Acetone,42780,-0.0140715859971967,0.00453118260250517,-0.0229527038981068,-0.00519046809628652,0.00190348759652418
PLA2G1B,Phospholipase A2,NMR metabolomics,X23478.Creatinine,42464,0.14099213416168,0.0049008308981468,0.131386505601312,0.150597762722048,1.30098367937686e-176
PLA2G1B,Phospholipase A2,NMR metabolomics,X23479.Albumin,42779,-0.0150164984164534,0.00451484815842297,-0.0238656008069625,-0.00616739602594441,0.000883275207260366
PLA2G1B,Phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,42782,0.019770955882596,0.00477946992915384,0.0104031948214545,0.0291387169437375,3.54546152188274e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42782,-0.0171223020077518,0.00481762556414899,-0.0265648481134838,-0.00767975590201976,0.000380568202603037
PLA2G1B,Phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42782,-0.0178495620329997,0.00476338364962698,-0.0271857939862686,-0.00851333007973084,0.000179527910128027
PLA2G1B,Phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42782,-0.0168520636679918,0.00482592242479047,-0.0263108716205812,-0.00739325571540251,0.00048096268557616
PLA2G1B,Phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42782,-0.0164129005131659,0.00478095896609874,-0.0257835800867194,-0.00704222093961237,0.000598782482698868
PLA2G1B,Phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42782,-0.0160346088849354,0.0047251833385673,-0.0252959682285273,-0.00677324954134345,0.000692186817233643
PLA2G1B,Phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42782,-0.0174900966513714,0.00482560360017934,-0.0269482797077229,-0.00803191359501993,0.000290648962157631
PLA2G1B,Phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42782,-0.0193192246063526,0.00471699488531868,-0.0285645345815773,-0.010073914631128,4.23399759484303e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42782,-0.0158343741137107,0.00479939787856516,-0.0252411939556984,-0.00642755427172295,0.000971957234611731
PLA2G1B,Phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42782,-0.0156226467438819,0.00477479327698777,-0.0249812415667779,-0.00626405192098588,0.00107093742732341
PLA2G1B,Phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42782,-0.0146506071717198,0.00475963201673948,-0.0239794859245292,-0.00532172841891046,0.00208742305381004
PLA2G1B,Phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42782,-0.0107580257236653,0.00465256618180886,-0.0198770554400107,-0.00163899600731992,0.0207772479014065
PLA2G1B,Phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42782,-0.00822204273750044,0.00457978215354736,-0.0171984157584533,0.000754330283452386,0.0726295246534665
PLA2G1B,Phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42782,-0.0132558400731653,0.00472356676995828,-0.0225140309422836,-0.00399764920404709,0.00501821918728989
PLA2G1B,Phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42782,-0.0183030010098343,0.00480234778433042,-0.0277156026671219,-0.00889039935254664,0.000138869601917468
PLA2G1B,Phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42782,-0.0126971468215979,0.00474200071580142,-0.0219914682245687,-0.00340282541862712,0.00742424279785777
PLA2G1B,Phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,42782,-0.01319079852382,0.00471578468666066,-0.0224337365096749,-0.00394786053796514,0.00516266810041321
PLA2G1B,Phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,42782,-0.012372931091632,0.00473937450100906,-0.0216621051136097,-0.00308375706965421,0.00904649096025367
PLA2G1B,Phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,42782,-0.00727438662491518,0.00464582884957999,-0.016380211170092,0.00183143792026161,0.117421363507216
PLA2G1B,Phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42782,-0.00328766069326385,0.00456520677389769,-0.0122354659701033,0.00566014458357561,0.47144138671561
PLA2G1B,Phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42782,-0.0110408582419569,0.00473041722303108,-0.0203124759990978,-0.00176924048481596,0.0196095077477805
PLA2G1B,Phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,42782,-0.016659096962931,0.00471079127222866,-0.0258922478564992,-0.00742594606936281,0.000407018367520211
PLA2G1B,Phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42782,-0.00818352182978439,0.00444884000501405,-0.0169032482396119,0.000536204580043156,0.0658674230827583
PLA2G1B,Phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42782,-0.010337695373619,0.00449717441414265,-0.0191521572253386,-0.00152323352189942,0.0215365716302884
PLA2G1B,Phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42782,-0.00881992934102353,0.00443001167336517,-0.0175027522208193,-0.000137106461227792,0.0465064368892662
PLA2G1B,Phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42782,-0.00328383848846313,0.00434876146024647,-0.0118074109505462,0.00523973397361995,0.450189832578326
PLA2G1B,Phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42782,-0.000681950192888189,0.0043605423197019,-0.00922861313950392,0.00786471275372754,0.875727042324277
PLA2G1B,Phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42782,-0.00668495534368026,0.0043983932738153,-0.0153058061603582,0.00193589547299773,0.128568670011297
PLA2G1B,Phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42782,-0.0135642063878172,0.00467088144157273,-0.0227191340132997,-0.00440927876233464,0.00369029909319877
PLA2G1B,Phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42782,-0.003878542212349,0.00459395166174152,-0.0128826874693624,0.00512560304466438,0.398532601881538
PLA2G1B,Phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,42782,-0.00670605939523524,0.00458067737599499,-0.0156841870521854,0.00227206826171494,0.143220200012713
PLA2G1B,Phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,42782,-0.00518153639673524,0.00447198645830629,-0.0139466298550156,0.00358355706154508,0.246612923982377
PLA2G1B,Phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,42782,-0.00397791666029629,0.0044284571027724,-0.0126576925817302,0.00470185926113762,0.369061570609857
PLA2G1B,Phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42782,-0.00335338379364727,0.00445130895399578,-0.012077949343479,0.00537118175618445,0.451253996250078
PLA2G1B,Phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42782,-0.00495172377078627,0.00439536016611706,-0.0135666296963757,0.00366318215480315,0.25994009865979
PLA2G1B,Phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,42782,-0.0086081708216086,0.00475623550565399,-0.0179303924126904,0.000714050769473231,0.0703379400777808
PLA2G1B,Phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42782,-0.0162985779162077,0.00447179648617481,-0.0250632990291103,-0.00753385680330503,0.000268650447473981
PLA2G1B,Phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42782,-0.0172802696650161,0.004514955390351,-0.0261295822301041,-0.00843095709992818,0.000130116093206854
PLA2G1B,Phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42782,-0.0123372978749018,0.00452050884495427,-0.0211974952110121,-0.00347710053879139,0.00635730807471434
PLA2G1B,Phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42782,-0.0186230678330013,0.00445036844414212,-0.0273457899835199,-0.00990034568248275,2.87449000036441e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42782,-0.020303889752224,0.0044537784635169,-0.0290332955407171,-0.0115744839637309,5.18954838593872e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42782,-0.0139410330572229,0.00447916384081061,-0.0227201941852117,-0.00516187192923409,0.00185946094210912
PLA2G1B,Phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42782,-0.0131880724400365,0.00475314517191602,-0.0225042369769919,-0.0038719079030811,0.00553452653809251
PLA2G1B,Phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,42782,-0.0193314159803105,0.00432792619054617,-0.027814151313781,-0.01084868064684,8.00877945220787e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,42782,-0.0258375086010352,0.00445102417778293,-0.0345615159894898,-0.0171135012125807,6.58636004923836e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,42782,-0.0206419106368014,0.00446442220270827,-0.0293921781541095,-0.0118916431194932,3.80526422497019e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,42782,-0.0257809883843109,0.00444770787295526,-0.0344984958153032,-0.0170634809533186,6.92302699704003e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42782,-0.0278965944269238,0.00444995866626216,-0.0366185134127976,-0.0191746754410499,3.74468128481912e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,42782,-0.0191233607573868,0.0044389945360514,-0.0278237900480476,-0.0104229314667261,1.65865693520433e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,42782,-0.021389758084376,0.0047521307271049,-0.0307039343095016,-0.0120755818592504,6.81683885049827e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,42782,-0.00437644986974837,0.00435513169551949,-0.0129125079929666,0.00415960825346983,0.314965328222577
PLA2G1B,Phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,42782,-0.020094287234578,0.00441381585298673,-0.028745366306432,-0.011443208162724,5.34499090339531e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,42782,-0.020053393664643,0.00438169310837902,-0.0286415121570659,-0.0114652751722202,4.76709537435956e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,42782,-0.0188165667680453,0.00442338391567488,-0.0274863992427681,-0.0101467342933225,2.11499602349321e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42782,-0.0190020685424999,0.00442372990234031,-0.0276725791510869,-0.0103315579339129,1.75522363933046e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42782,-0.0178516907970301,0.00442973137613668,-0.026533964294258,-0.0091694172998022,5.608759109292e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,42782,-0.0245508265739118,0.0047455832652556,-0.0338521697738128,-0.0152494833740108,2.33136857557655e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42782,-0.0119974131455655,0.00438360722288582,-0.0205892833024218,-0.00340554298870933,0.00621052770772029
PLA2G1B,Phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,42782,-0.0167888574800604,0.00440523082511551,-0.0254231098972868,-0.00815460506283397,0.000138949525841874
PLA2G1B,Phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,42782,-0.0155244220235138,0.00439636928601248,-0.0241413058240983,-0.00690753822292933,0.000415062234034983
PLA2G1B,Phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,42782,-0.0164018397692142,0.00439593249940265,-0.0250178674680434,-0.007785812070385,0.000191391424667826
PLA2G1B,Phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42782,-0.0175933804731123,0.00441911819496388,-0.0262548521352415,-0.00893190881098314,6.8925816538534e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42782,-0.0122675316754403,0.00438278132675215,-0.0208577830758745,-0.00367728027500606,0.00513287920993348
PLA2G1B,Phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,42782,-0.0189988104859303,0.00476617188426906,-0.0283405073790977,-0.00965711359276295,6.74970970608495e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,42782,-0.00844544075257614,0.00435826205213526,-0.0169876343747613,9.67528696089754e-05,0.0526683042310591
PLA2G1B,Phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,42782,-0.0115000296559124,0.00436129901924189,-0.0200481757336265,-0.00295188357819831,0.00837785124357931
PLA2G1B,Phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,42782,-0.00754110287379067,0.00432604903467409,-0.0160201589817519,0.000937953234170547,0.0813239601810187
PLA2G1B,Phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,42782,-0.0118525559113728,0.00436114232735105,-0.0204003948729808,-0.00330471694976471,0.0065808001280783
PLA2G1B,Phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42782,-0.0141926619059422,0.00438828785560896,-0.0227937061029358,-0.00559161770894869,0.00122269502870567
PLA2G1B,Phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42782,-0.00509565937592742,0.00434897199018848,-0.0136196444766968,0.00342832572484201,0.241340939776005
PLA2G1B,Phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,42782,-0.0151419457464813,0.00479523869714304,-0.0245406135928816,-0.00574327790008091,0.00159364652731805
PLA2G1B,Phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42782,-0.00851111919289952,0.00498550981833123,-0.0182827184368287,0.0012604800510297,0.087813066843755
PLA2G1B,Phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42782,-0.00617775873837303,0.00501208752361458,-0.0160014502846576,0.00364593280791154,0.217756814648368
PLA2G1B,Phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42782,-0.00582828226184034,0.0050471984623256,-0.0157207912479985,0.00406422672431784,0.248210703338315
PLA2G1B,Phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42782,-0.00433957856936079,0.00495780522154496,-0.0140568768035889,0.00537771966486733,0.38142488653897
PLA2G1B,Phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42782,-0.00539661602355466,0.00500770273006308,-0.0152117133744783,0.00441848132736898,0.281203300410664
PLA2G1B,Phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42782,-0.000821368867916695,0.00474770276184457,-0.010126866281132,0.00848412854529866,0.862651307436048
PLA2G1B,Phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42782,-0.0149311859264932,0.00467888565676432,-0.0241018018137513,-0.00576057003923514,0.00142013169196337
PLA2G1B,Phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,42782,-0.0266593327197999,0.00520150098724447,-0.036854274654799,-0.0164643907848007,3.01116958259452e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,42782,-0.0302835224547379,0.00520989439703384,-0.0404949154729242,-0.0200721294365516,6.2855083808859e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,42782,-0.0352558846167847,0.00520518643343935,-0.0454580500263259,-0.0250537192072436,1.31125199444545e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,42782,-0.0219517452802838,0.00515633091183774,-0.0320581538674858,-0.0118453366930819,2.08354539884197e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42782,-0.0195070391762094,0.00514738972744824,-0.029595923042008,-0.00941815531041087,0.000151483431572449
PLA2G1B,Phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42782,-0.0285097921975567,0.0051649953406805,-0.0386331830652904,-0.0183864013298229,3.45585735063862e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,42782,-0.0285432065400034,0.0048232670697052,-0.0379968099966256,-0.0190896030833812,3.34101973282133e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42782,-0.0535301567789726,0.00485097296763757,-0.0630380637955422,-0.044022249762403,3.41524634977953e-28
PLA2G1B,Phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,42782,-0.05640320404077,0.00480946055985913,-0.0658297467380939,-0.0469766613434461,1.30764372088367e-31
PLA2G1B,Phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,42782,-0.0593197612989538,0.00478302204666414,-0.0686944845104155,-0.049945038087492,3.94079086552847e-35
PLA2G1B,Phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,42782,-0.0494651978461734,0.00484100736804559,-0.0589535722875428,-0.0399768234048041,2.01936923961011e-24
PLA2G1B,Phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42782,-0.0478058563424949,0.00481749252924144,-0.0572481416998081,-0.0383635709851817,3.94787540443956e-23
PLA2G1B,Phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42782,-0.0543898626057179,0.00492091895537149,-0.064034863758246,-0.0447448614531898,2.80457842588751e-28
PLA2G1B,Phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,42782,-0.0360015563954713,0.00467338606448441,-0.0451613930818607,-0.0268417197090818,1.41500432085141e-14
PLA2G1B,Phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,42782,-0.0451199356038939,0.00446162280979969,-0.0538647163111013,-0.0363751548966866,5.88700011435676e-24
PLA2G1B,Phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,42782,-0.054603411936163,0.00448840958146216,-0.0634006947158288,-0.0458061291564972,7.12461615510111e-34
PLA2G1B,Phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,42782,-0.0596176129526953,0.00451116418263048,-0.068459494750651,-0.0507757311547395,1.25249653490102e-39
PLA2G1B,Phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,42782,-0.0444095208504882,0.00445760777189299,-0.0531464320833985,-0.035672609617578,2.66961642936269e-23
PLA2G1B,Phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42782,-0.0403823680218073,0.00443711339793855,-0.0490791102817668,-0.0316856257618477,1.01758917538657e-19
PLA2G1B,Phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42782,-0.0511452050200824,0.00456399795499428,-0.0600906410118712,-0.0421997690282937,5.09404324745331e-29
PLA2G1B,Phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,42782,-0.0227595355817522,0.0047619296939874,-0.0320929177819675,-0.0134261533815369,1.77591636654461e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42284,0.0161004588950212,0.00456650126743226,0.00715011641085401,0.0250508013791885,0.000423687986677541
PLA2G1B,Phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42284,0.0184413241255594,0.00471000550535591,0.00920971333506177,0.0276729349160569,9.07305562356093e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42284,0.0149430092068236,0.00466138813356676,0.00580668846503277,0.0240793299486145,0.00135058115551818
PLA2G1B,Phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42284,0.0211757727211651,0.00473050055458877,0.0119039916341712,0.0304475538081591,7.65413639654078e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42284,-0.0182863330691959,0.00467776151607691,-0.0274547456407067,-0.00911792049768518,9.30667435359077e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42661,0.0113629089963455,0.00454429557354352,0.00245608967220016,0.0202697283204908,0.0124143895814454
PLA2G1B,Phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42661,0.0231055178461669,0.00475818847603512,0.0137794684331381,0.0324315672591957,1.21157797384193e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42661,0.021571537598655,0.0047647163010651,0.0122326936485674,0.0309103815487426,6.024017698261e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42661,0.0253694450733973,0.00469420089282678,0.0161688113234568,0.0345700788233378,6.61244992701057e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42661,-0.0238986997453481,0.00466689714721604,-0.0330458181538915,-0.0147515813368046,3.08282743672168e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42781,0.00171353393826111,0.00465902583169641,-0.00741815669186385,0.0108452245683861,0.71303702309356
PLA2G1B,Phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42781,0.026876528120947,0.00451877590267536,0.0180197273517033,0.0357333288901907,2.78540431179965e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42781,0.0291066274711566,0.00464815255458996,0.0199962484641603,0.0382170064781529,3.91570068788967e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42781,0.0149616588288781,0.00446336804935428,0.00621345745214373,0.0237098602056125,0.000804196903226738
PLA2G1B,Phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42781,-0.0207495814665434,0.00444538771730396,-0.0294625413924592,-0.0120366215406277,3.07553527202391e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42782,0.00393194372098793,0.00452091853266613,-0.00492905660303768,0.0127929440450135,0.384467538494743
PLA2G1B,Phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42782,0.0108843816850932,0.00469410918717938,0.00168392767822157,0.0200848356919648,0.0204243273499942
PLA2G1B,Phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42782,0.0112615044170166,0.00474239306861881,0.00196641400252371,0.0205565948315095,0.0175795947130941
PLA2G1B,Phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42782,0.00907586407301826,0.00457965026705937,9.97495495818901e-05,0.0180519785964546,0.0475238701068108
PLA2G1B,Phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42782,-0.0096437187920023,0.00465204269834258,-0.0187617224807538,-0.000525715103250848,0.0381903976525642
PLA2G1B,Phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42782,0.0043521327540698,0.00468031716253996,-0.00482128888450852,0.0135255543926481,0.352449801299384
PLA2G1B,Phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42782,0.0051928621560135,0.00455836597313417,-0.00374153515132947,0.0141272594633565,0.254642422281751
PLA2G1B,Phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42782,0.00713001594896229,0.0044689614074648,-0.00162914840966871,0.0158891803075933,0.110634325028878
PLA2G1B,Phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42782,0.0014125226046516,0.00469791964174649,-0.00779539989317152,0.0106204451024747,0.763670892564535
PLA2G1B,Phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42782,-0.00505205162841406,0.00459963893671562,-0.0140673439443767,0.00396324068754855,0.272067522848134
PLA2G1B,Phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42782,0.03763033836637,0.00456727531729974,0.0286784787444625,0.0465821979882775,1.89243314286815e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42782,-0.0110308504807781,0.00473439517571433,-0.0203102650251781,-0.00175143593637797,0.0198239608577337
PLA2G1B,Phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42782,-0.0147020957346954,0.00477293477701324,-0.0240570478976413,-0.00534714357174941,0.00207201546935015
PLA2G1B,Phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42782,0.0133262971916149,0.00448454411917036,0.00453659071804101,0.0221160036651888,0.00296765588216219
PLA2G1B,Phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42782,0.00388700400548245,0.00471492664724324,-0.0053542522231143,0.0131282602340792,0.409724559636053
PLA2G1B,Phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42782,0.0381738217488927,0.00430246981752075,0.029740980906552,0.0466066625912334,8.03284827810446e-19
PLA2G1B,Phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42782,-0.020416670021858,0.00456494100091402,-0.0293639543836495,-0.0114693856600665,7.79396528835174e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42782,-0.0314721486889861,0.004552825292001,-0.0403956862613081,-0.0225486111166642,4.96860337974312e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42782,0.0160832916577876,0.00438588547873582,0.00748695611946536,0.0246796271961098,0.000246294324312507
PLA2G1B,Phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42782,0.00742859465599251,0.00471206871326496,-0.00180706002200682,0.0166642493339918,0.114933002467484
PLA2G1B,Phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42782,0.00324405418035411,0.0043755103265884,-0.00533194605975915,0.0118200544204674,0.458456716964361
PLA2G1B,Phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42782,0.000778459850222794,0.00474032664508561,-0.008512580374145,0.0100695000745906,0.869559833663784
PLA2G1B,Phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42782,0.000148752375049299,0.00442172875156732,-0.00851783597802266,0.00881534072812125,0.973163741607191
PLA2G1B,Phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42782,-0.00340828204782167,0.0047356982422061,-0.0126902506025456,0.00587368650690229,0.471722101473717
PLA2G1B,Phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42782,-0.000680428096906737,0.00472997207391821,-0.00995117336178643,0.00859031716797295,0.885617443928795
PLA2G1B,Phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42782,0.0141630768096062,0.00448658112340416,0.00536937780773401,0.0229567758114783,0.00159879135301044
PLA2G1B,Phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42782,-0.00728938843716824,0.00437070634077964,-0.0158559728650963,0.00127719599075986,0.0953819132352012
PLA2G1B,Phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42782,-0.0163233482726309,0.0045226284079119,-0.0251876999521382,-0.00745899659312359,0.000308173813556838
PLA2G1B,Phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42782,0.0120665163390368,0.00483767207590804,0.00258467907025706,0.0215483536078166,0.0126330247638254
PLA2G1B,Phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42782,1.31202453513532e-05,0.00464822400187625,-0.00909739879832609,0.0091236392890288,0.997747906578677
PLA2G1B,Phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42782,0.0204084004286124,0.00442961910400666,0.0117263469847593,0.0290904538724654,4.11721264111487e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42782,-0.0120324426865501,0.00446577798403138,-0.0207853675352516,-0.00327951783784855,0.00706092345387782
PLA2G1B,Phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42782,-0.0220336411961298,0.00443375045582253,-0.030723792089542,-0.0133434903027177,6.7933703131649e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42782,0.0130665905029907,0.00474289416815225,0.00377051793341227,0.0223626630725691,0.0058773405276037
PLA2G1B,Phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42782,-0.00612326857051662,0.00473937636627987,-0.0154124462484252,0.00316590910739194,0.196379533934766
PLA2G1B,Phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42772,-0.0073900882064213,0.00493552959686742,-0.0170637262162814,0.00228354980343884,0.134332149782275
PLA2G1B,Phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42772,0.0141026492281585,0.00466149649341482,0.00496611610106542,0.0232391823552515,0.00248811830039882
PLA2G1B,Phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42772,0.00136326324679566,0.0045295256632524,-0.00751460705317905,0.0102411335467704,0.763439974764411
PLA2G1B,Phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42772,0.0136404736887174,0.00515908907772714,0.00352865909637218,0.0237522882810626,0.00820342512607363
PLA2G1B,Phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42772,-0.00502921153987132,0.00492097768515256,-0.0146743278027703,0.00461590472302769,0.306801768168741
PLA2G1B,Phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42782,-0.0288807306614981,0.0047873129638512,-0.0382638640706465,-0.0194975972523498,1.65365914450765e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42782,0.0144430632866241,0.00495060078148673,0.00473988575491009,0.0241462408183381,0.0035349951850824
PLA2G1B,Phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42782,0.0189969166445655,0.00498301130832437,0.00923021448024978,0.0287636188088813,0.000138267135037591
PLA2G1B,Phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42782,-0.0129714272586845,0.0046998882556332,-0.0221832082397256,-0.0037596462776434,0.00578887694702225
PLA2G1B,Phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42782,0.00356069167696994,0.0048976840330727,-0.00603876902785256,0.0131601523817924,0.467229051540641
PLA2G1B,Phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42782,-0.00369729253569649,0.00487237657992818,-0.0132471506323557,0.00585256556096275,0.447969013769766
PLA2G1B,Phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42782,0.00199905225537245,0.00483172382313765,-0.00747112643797734,0.0114692309487222,0.679074873048022
PLA2G1B,Phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42782,0.00964964461028674,0.00480246658465478,0.000236810104363374,0.0190624791162101,0.0445239950677637
PLA2G1B,Phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42782,-0.0326769110057055,0.00504183498293025,-0.0425589075722488,-0.0227949144391622,9.41643618906144e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42782,-0.00108842473871435,0.00476725069354141,-0.0104322360980555,0.0082553866206268,0.819406447233756
PLA2G1B,Phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42782,-0.0394976323374823,0.00465497174152948,-0.0486213769508801,-0.0303738877240845,2.37761704538682e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42782,0.0225565615615063,0.00466047073245029,0.0134220389259038,0.0316910841971089,1.31282893136467e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42782,0.0199036744561837,0.00470691672970191,0.010678117665968,0.0291292312463995,2.36687329280342e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42782,0.00671168034344212,0.00465278881008283,-0.00240778572432022,0.0158311464112045,0.149182452659059
PLA2G1B,Phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42782,0.00353205396986102,0.00481249090882393,-0.00590042821143388,0.0129645361511559,0.46300121352402
PLA2G1B,Phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52327,0.00743375028721108,0.00381730657015501,-4.81705902927385e-05,0.0149156711647149,0.0515011568505599
PLA2G1B,Phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52327,0.00539800491345996,0.00371493431612075,-0.0018832663461367,0.0126792761730566,0.146221971232784
PLA2G1B,Phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50852,-0.000728758920317661,0.00353644856284901,-0.00766019810350172,0.0062026802628664,0.836737514406187
PLA2G1B,Phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50852,0.00649779982790527,0.00388839100689386,-0.0011234465456067,0.0141190462014172,0.0947209656899223
PLA2G1B,Phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50852,0.00232381578279161,0.00379115152070834,-0.00510684119779673,0.00975447276337995,0.53991069927837
PLA2G1B,Phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50852,-0.00488007773044223,0.00345522471996558,-0.0116523181815748,0.00189216272069032,0.157853540283332
PLA2G1B,Phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,52327,-0.0903181273824285,0.053604653801712,-0.195383248833784,0.014746994068927,0.0920226295405499
PLA2G1B,Phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,52327,-0.000929079415180223,0.00333054169569577,-0.00745694113874393,0.00559878230838348,0.780279973379571
PLA2G1B,Phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,52327,-0.00178525209328203,0.00329000124751776,-0.00823365453841685,0.00466315035185278,0.587390075359278
PLA2G1B,Phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,52327,6.78838190268818e-05,0.00335475428185233,-0.00650743457340369,0.00664320221145745,0.98385599508921
PLA2G1B,Phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,52327,-0.0565020061801741,0.0375063669610226,-0.130014485423778,0.0170104730634302,0.13196165728123
PLA2G1B,Phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,52327,-0.060831981884309,0.0364240490630374,-0.132223118047862,0.0105591542792444,0.0949121455202653
PLA2G1B,Phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52327,0.00851299322872639,0.00379358794959922,0.00107756084751193,0.0159484256099409,0.0248387344053013
PLA2G1B,Phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52327,0.00812432881937511,0.00378515032361427,0.00070543418509115,0.0155432234536591,0.0318539295021578
PLA2G1B,Phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52327,0.0084884590493072,0.00374331135862489,0.00115156878640242,0.015825349312212,0.0233607233624819
PLA2G1B,Phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,52272,0.00595199236510283,0.0037321760610281,-0.00136307271451226,0.0132670574447179,0.110775576457224
PLA2G1B,Phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,52327,-0.00456306309740901,0.00334933228776372,-0.0111277543814259,0.00200162818660788,0.173091277199656
PLA2G1B,Phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,52327,-0.00456691409520062,0.00335009990380874,-0.0111331099066657,0.00199928171626451,0.172827308748567
PLA2G1B,Phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,52327,-0.00456310210429999,0.00334936269005595,-0.0111278529768097,0.00200164876820967,0.17309150440145
PLA2G1B,Phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52327,-0.00459510781029045,0.00334951014315907,-0.0111601476908822,0.00196993207030133,0.170115789852394
PLA2G1B,Phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52327,-0.00460730103385676,0.0033494442724666,-0.0111722118078913,0.00195760974017778,0.168976814977
PLA2G1B,Phospholipase A2,Health and medical history,X2405.Number of children fathered,40227,-0.0649060246732919,0.0413950708077829,-0.146040363456546,0.0162283141099627,0.116917964643726
PLA2G1B,Phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",50009,-0.00733172780177358,0.00388912520239716,-0.014954413198472,0.000290957594924858,0.059418527963786
PLA2G1B,Phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",50009,0.00908175391605715,0.00349164687781113,0.00223812603554734,0.015925381796567,0.00930197144804609
PLA2G1B,Phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",50009,-0.0012919900946782,0.00354074271687807,-0.00823184581975922,0.00564786563040281,0.715195437570441
PLA2G1B,Phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",50009,-0.00882398788448099,0.00364179262357217,-0.0159619014266824,-0.00168607434227953,0.0154022804560763
PLA2G1B,Phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",50009,0.0078933509852901,0.00350879485613735,0.0010161130672609,0.0147705889033193,0.0244853678116735
PLA2G1B,Phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",50009,-0.00533451660839352,0.00356704102487223,-0.0123259170171431,0.00165688380035606,0.134798666378606
PLA2G1B,Phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52470,-0.00759965428849208,0.00374847824518408,-0.0149466716490529,-0.000252636927931288,0.0426331799427927
PLA2G1B,Phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52470,-0.0126302474872187,0.00350282194848986,-0.0194957785062588,-0.00576471646817856,0.000311921204707434
PLA2G1B,Phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,52470,0.0043176569142087,0.00330232563900656,-0.00215490133824417,0.0107902151666616,0.19106962723439
PLA2G1B,Phospholipase A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35606,-0.0312467787614677,0.0509904466275917,-0.131188054151547,0.068694496628612,0.540032488591352
PLA2G1B,Phospholipase A2,Health and medical history,X2704.Years since last cervical smear test,38547,-0.0531085154575035,0.0449063556923205,-0.141124972614452,0.0349079416994446,0.236977827669721
PLA2G1B,Phospholipase A2,Health and medical history,X2714.Age when periods started (menarche),41023,-0.00827179252252619,0.0355201097582177,-0.0778912076486329,0.0613476226035805,0.815861474337491
PLA2G1B,Phospholipase A2,Health and medical history,X2734.Number of live births,41379,-0.0186106533753382,0.0343311740500573,-0.0858997545134505,0.0486784477627741,0.587765076761537
PLA2G1B,Phospholipase A2,Health and medical history,X2744.Birth weight of first child,39518,-0.0849848180139494,0.0368258150980491,-0.157163415606126,-0.0128062204217732,0.0210326709230462
PLA2G1B,Phospholipase A2,Health and medical history,X2754.Age at first live birth,38273,-0.000167479157458506,0.00586085013221521,-0.0116547454166003,0.0113197871016833,0.977203448986045
PLA2G1B,Phospholipase A2,Health and medical history,X2764.Age at last live birth,38244,0.00269995385893268,0.00537081396152818,-0.00782684150566255,0.0132267492235279,0.615181460134783
PLA2G1B,Phospholipase A2,Health and medical history,X2794.Age started oral contraceptive pill,37168,0.00991384105672148,0.00837268906001821,-0.0064966295009142,0.0263243116143572,0.236421063528663
PLA2G1B,Phospholipase A2,Health and medical history,X2804.Age when last used oral contraceptive pill,36376,0.00822245924429243,0.00623236460412007,-0.00399297537978291,0.0204378938683678,0.187105494499897
PLA2G1B,Phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,36351,-0.011547445098951,0.00638748261836172,-0.02406691103094,0.000972020833037948,0.0706758373154524
PLA2G1B,Phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36147,-0.000563572452891032,0.0613487054426855,-0.120807035120555,0.119679890214773,0.992670696825897
PLA2G1B,Phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36144,0.0614834962165404,0.0671651656343173,-0.0701602284267216,0.193127220859802,0.360009512075866
PLA2G1B,Phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36159,-0.0246308929485347,0.069820256743228,-0.161478596165262,0.112216810268192,0.724267248367544
PLA2G1B,Phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36134,-0.0645490562380941,0.0681435363972119,-0.198110387576629,0.0690122751004413,0.343543709549204
PLA2G1B,Phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,36166,-0.00293175315951702,0.0517568657368503,-0.104375210003744,0.0985117036847096,0.95482983431547
PLA2G1B,Phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,36188,-0.0790114541033794,0.0572954731693716,-0.191310581515348,0.0332876733085888,0.167933507332701
PLA2G1B,Phospholipase A2,Mental health,X28741.Difficulty learning a new task,36127,-0.0746778718606138,0.0664370566628761,-0.204894502919851,0.0555387591986234,0.261035229228992
PLA2G1B,Phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,35854,-0.0495544273285633,0.0707151108818874,-0.188156044657063,0.089047189999936,0.483476359026871
PLA2G1B,Phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36144,-0.00957233563476884,0.0594421791065264,-0.126079006683561,0.106934335414023,0.872069664674954
PLA2G1B,Phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36190,0.0140848935237374,0.0899736934065202,-0.162263545553042,0.190433332600517,0.875608306149395
PLA2G1B,Phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,35866,-0.0688644225913482,0.0480691434499321,-0.163079943753215,0.0253510985705187,0.152015654680242
PLA2G1B,Phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,36352,-0.00415377185223402,0.00602479868914663,-0.0159623772829614,0.00765483357849336,0.490565146800049
PLA2G1B,Phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35447,-0.0102951379627814,0.013410484305475,-0.0365796872015124,0.0159894112759496,0.442698448789106
PLA2G1B,Phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35447,0.00306892300420039,0.0150629158706317,-0.0264543921022378,0.0325922381106385,0.838563077447099
PLA2G1B,Phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35447,-0.0312533230934944,0.0491417892542556,-0.127571230031835,0.0650645838448465,0.524811036553614
PLA2G1B,Phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35447,0.0021648596995386,0.0573613476133803,-0.110263381622687,0.114593101021764,0.969895598156988
PLA2G1B,Phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35447,0.0306987563370625,0.0706175580199677,-0.107711657382074,0.169109170056199,0.663781795928574
PLA2G1B,Phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35447,-0.00763500102575253,0.0591179981637852,-0.123506277426771,0.108236275375266,0.897244296350956
PLA2G1B,Phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35447,0.0333788290261343,0.0244410473706394,-0.014525623820319,0.0812832818725875,0.172086239541574
PLA2G1B,Phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35447,-0.0341450217768403,0.0412914186387607,-0.115076202308811,0.0467861587551306,0.408309541743865
PLA2G1B,Phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35403,-0.118493072581937,0.0696797033044887,-0.255065291058735,0.0180791458948611,0.089079627861346
PLA2G1B,Phospholipase A2,Mental health,X29003.Recent feelings of depression,35391,-0.0592288382887115,0.0686489207549623,-0.193780722968438,0.0753230463910146,0.388292457000545
PLA2G1B,Phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35403,0.0222936401563004,0.053577695059125,-0.0827186421595845,0.127305922472185,0.677351745207856
PLA2G1B,Phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,35407,-0.122056647567806,0.053049163826211,-0.22603300866718,-0.0180802864684329,0.0214346998094345
PLA2G1B,Phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,35417,-0.133957362215798,0.0810006377383791,-0.292718612183021,0.0248038877514255,0.0982223538568855
PLA2G1B,Phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,35383,0.00223507754169826,0.0775855552116961,-0.149832610673226,0.154302765756623,0.977018722919018
PLA2G1B,Phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,35415,0.0416251442776548,0.0747385412674072,-0.104862396606463,0.188112685161773,0.577586078765701
PLA2G1B,Phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35408,0.195062889082342,0.127820869338376,-0.055466014820876,0.44559179298556,0.12704471519882
PLA2G1B,Phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,35387,-0.0657251787265331,0.142606450786804,-0.345233822268669,0.213783464815603,0.644897279902748
PLA2G1B,Phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,36438,0.0221643307214093,0.0278523189887218,-0.0324262144964854,0.0767548759393041,0.426185736506474
PLA2G1B,Phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36438,0.0165522306270076,0.0729856173732203,-0.126499579424504,0.159604040678519,0.820595330744359
PLA2G1B,Phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36438,0.0184590891710715,0.0285508483956417,-0.0375005736843862,0.0744187520265292,0.517954182665261
PLA2G1B,Phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36438,0.035672809568823,0.0878351453336396,-0.136484075285111,0.207829694422757,0.684656386902779
PLA2G1B,Phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36438,-0.0535804647811259,0.0729385803837023,-0.196540082333182,0.0893791527709306,0.462608723226574
PLA2G1B,Phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36438,0.0471557707561759,0.0761237751244816,-0.102046828487808,0.19635837000016,0.535631661612159
PLA2G1B,Phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36438,-0.188047428019389,0.0788280509163546,-0.342550407815444,-0.0335444482233341,0.017079638225926
PLA2G1B,Phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36438,-0.00645146193168877,0.0770510435816535,-0.15747150735173,0.144568583488352,0.933273644400157
PLA2G1B,Phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36438,0.057202982829103,0.0505186815269157,-0.0418136329636517,0.156219598621858,0.257540153733327
PLA2G1B,Phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36438,0.0134421102342769,0.0256367741862386,-0.0368059671707507,0.0636901876393045,0.600065608215808
PLA2G1B,Phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36438,0.0337257907248497,0.0456737213043618,-0.0557947030316994,0.123246284481399,0.460291147279911
PLA2G1B,Phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36438,0.029294063642598,0.0701244510449088,-0.108149860405423,0.166737987690619,0.676146732287191
PLA2G1B,Phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36438,-0.0109512402448932,0.100781335537272,-0.208482657897946,0.186580177408159,0.913472500437185
PLA2G1B,Phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36438,0.116790935033427,0.0675408910770728,-0.0155892114776352,0.24917108154449,0.083817958811931
PLA2G1B,Phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36438,0.0251049894743381,0.0952940613034048,-0.161671370680335,0.211881349629012,0.792213117849321
PLA2G1B,Phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36438,0.145441715163923,0.0953422292642814,-0.041429054194069,0.332312484521914,0.127185554096573
PLA2G1B,Phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36438,-0.0201747735901555,0.0553275404642965,-0.128616752900177,0.0882672057198658,0.715388917221583
PLA2G1B,Phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36438,0.0492031100813964,0.0512309527778078,-0.0512095573631069,0.1496157775259,0.336877125161093
PLA2G1B,Phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36438,0.11020742556532,0.0736271495607666,-0.0341017875737825,0.254516638704422,0.13448071390729
PLA2G1B,Phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,35311,0.0458682741579825,0.0633908827069369,-0.0783778559476139,0.170114404263579,0.469352277064726
PLA2G1B,Phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,35324,0.0295062737595878,0.0646273366779087,-0.0971633061291133,0.156175853648289,0.648003328456292
PLA2G1B,Phospholipase A2,Mental health,X29060.Recent worrying too much about different things,35320,-0.00421741112638556,0.0599977389122328,-0.121812979394362,0.113378157141591,0.943962880882062
PLA2G1B,Phospholipase A2,Mental health,X29061.Recent trouble relaxing,35317,0.074306291782815,0.0650778787833099,-0.0532463506324724,0.201858934198102,0.253579464312179
PLA2G1B,Phospholipase A2,Mental health,X29062.Recent restlessness,35334,0.209582306514249,0.0968668139746817,0.0197233511238731,0.399441261904625,0.0305325177435105
PLA2G1B,Phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,35304,0.0115110235721826,0.0657532528046301,-0.117365351924892,0.140387399069258,0.861035194168093
PLA2G1B,Phospholipase A2,Mental health,X29064.Recent feelings of foreboding,35305,-0.00149226850727513,0.0745839791984787,-0.147676867736293,0.144692330721743,0.984037727057735
PLA2G1B,Phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36438,-0.000708356986536272,0.031955646920272,-0.0633414249502693,0.0619247109771968,0.982315447655991
PLA2G1B,Phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36438,0.169919275085546,0.0569843292613029,0.0582299897333921,0.2816085604377,0.00287456647355972
PLA2G1B,Phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36438,0.0515665946876904,0.0701494331078446,-0.0859262942036849,0.189059483579066,0.462304592616275
PLA2G1B,Phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36438,0.0906803198687526,0.0652488229503129,-0.0372073731138606,0.218568012851366,0.164643936985082
PLA2G1B,Phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,36438,0.0102299901524527,0.0489225109576973,-0.0856581313246341,0.10611811162954,0.834371377338595
PLA2G1B,Phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36438,0.0578801986383541,0.0523785115222813,-0.0447816839453173,0.160542081222025,0.269180212848473
PLA2G1B,Phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36438,-0.00285424211982674,0.052357142686444,-0.105474241785257,0.0997657575456034,0.956526475745947
PLA2G1B,Phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36438,-0.00571720589959676,0.0523605639528333,-0.10834391124715,0.0969094994479565,0.913055483764805
PLA2G1B,Phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36438,-0.0310376499723912,0.0676448199505651,-0.163621497075499,0.101546197130716,0.646368133921587
PLA2G1B,Phospholipase A2,Mental health,X29076.Felt loved as a child,35300,0.0565136812775047,0.0550122250449274,-0.0513102798105531,0.164337642365562,0.304323165665646
PLA2G1B,Phospholipase A2,Mental health,X29077.Physically abused by family as a child,35322,-0.179557691043542,0.0807335401499494,-0.337795429737442,-0.0213199523496407,0.0261795162554186
PLA2G1B,Phospholipase A2,Mental health,X29078.Felt hated by family member as a child,35307,-0.0696302491835665,0.0805930336487393,-0.227592595135096,0.0883320967679625,0.38763633698116
PLA2G1B,Phospholipase A2,Mental health,X29079.Sexually molested as a child,35264,-0.0490159042968431,0.103558374552861,-0.25199031842045,0.153958509826764,0.63600430470336
PLA2G1B,Phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,35280,0.0182514979972543,0.0754560744997713,-0.129642408022297,0.166145404016806,0.808879425106413
PLA2G1B,Phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35313,0.108282767077727,0.120517096797202,-0.12793074264479,0.344496276800243,0.368962558915733
PLA2G1B,Phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35266,0.066134797077217,0.0907146673806298,-0.111665950988817,0.243935545143251,0.466004131256401
PLA2G1B,Phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35320,-0.0706727449428688,0.104297462318662,-0.275095771087447,0.133750281201709,0.498046169708116
PLA2G1B,Phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35307,0.268567836446829,0.148621171957579,-0.0227296605900263,0.559865333483685,0.0708015941160476
PLA2G1B,Phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35306,0.0478029894268502,0.134831160465645,-0.216466085085813,0.312072063939513,0.722946745030755
PLA2G1B,Phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,35321,0.0558358397531065,0.127042215630897,-0.193166902883452,0.304838582389665,0.66031030304567
PLA2G1B,Phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,35315,-0.00483891951393117,0.0605162564610831,-0.123450782177654,0.113772943149792,0.93627116279426
PLA2G1B,Phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,35322,-0.138752898126189,0.0617754733648841,-0.259832825921362,-0.0176729703310165,0.0247341177166524
PLA2G1B,Phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,35328,-0.0398096810613811,0.0669017976748734,-0.170937204504133,0.0913178423813708,0.55183433715216
PLA2G1B,Phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35319,0.149810799216281,0.0791744034136589,-0.00537103147449083,0.304992629907052,0.0585165232900892
PLA2G1B,Phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,35318,-0.511517610074416,0.0509776723582678,-0.611433847896621,-0.411601372252211,1.63814476413856e-23
PLA2G1B,Phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34556,-0.334685880950513,0.0621206192930762,-0.456442294764942,-0.212929467136084,7.44227100842213e-08
PLA2G1B,Phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34579,-0.389040541248904,0.0637636230762397,-0.514017242478334,-0.264063840019474,1.1255909970792e-09
PLA2G1B,Phospholipase A2,Mental health,X29104.Ever used cannabis,35319,-0.0844989568970286,0.0891529122634507,-0.259238664933392,0.0902407511393347,0.34326968053244
PLA2G1B,Phospholipase A2,Mental health,X29108.Ever thought that life not worth living,35285,-0.0394491108556781,0.0681282949428519,-0.172980568943668,0.0940823472323116,0.562582579357846
PLA2G1B,Phospholipase A2,Mental health,X29109.Ever contemplated self-harm,35310,0.0300401272771192,0.103353591007562,-0.172532911097703,0.232613165651941,0.771325867120261
PLA2G1B,Phospholipase A2,Mental health,X29111.Ever self-harmed,35318,0.324028631814252,0.184760250559592,-0.0381014592825484,0.686158722911053,0.0795184249725192
PLA2G1B,Phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35307,0.105937694600578,0.100785066879251,-0.0916010364827537,0.30347642568391,0.293242780083009
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,37075,0.0494172881464361,0.0752160335935821,-0.0980061376969849,0.196840713989857,0.511197074645754
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,37075,-0.00251595253863371,0.055545728910187,-0.1113855812026,0.106353676125333,0.963873194839397
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,37075,-0.00189645495644651,0.0657804134976913,-0.130826065411921,0.127033155499028,0.977000835946362
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,37075,0.0608071010638963,0.0952975923353177,-0.125976179913326,0.247590382041119,0.523442785085652
PLA2G1B,Phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35298,0.0423064064128169,0.0575406903812984,-0.070473346734528,0.155086159560162,0.462219592050727
PLA2G1B,Phospholipase A2,Health and medical history,X29153.Pain or discomfort today,35309,-0.0440210541472653,0.0525216270037122,-0.146963443074541,0.0589213347800107,0.401978678495253
PLA2G1B,Phospholipase A2,Mental health,X29154.Anxiety or depression today,35309,0.0780562660337217,0.0678548573664012,-0.0549392544044245,0.211051786471868,0.250048202984222
PLA2G1B,Phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,35126,-0.0454511670531004,0.0518879110160547,-0.147151472644568,0.0562491385383668,0.381093217001227
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35292,-0.000187392178795908,0.012955712238805,-0.0255805881668536,0.0252058038092618,0.98846022665484
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35292,0.0300092545028546,0.0132821115560277,0.00397631585304034,0.0560421931526689,0.0238952967842949
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35292,-0.068237334874066,0.0165919595053946,-0.100757575504639,-0.0357170942434926,3.96244060100548e-05
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35292,0.0441764995880345,0.0153589744651504,0.0140729096363396,0.0742800895397294,0.00403805467338949
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35292,0.0117751258211547,0.0263954574619257,-0.0399599708042197,0.063510222446529,0.65553778011586
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35292,0.00473287193954055,0.0125351504050055,-0.0198360228542703,0.0293017667333514,0.705764664338214
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35290,0.022233796780957,0.0134466717216948,-0.00412167979356477,0.0485892733554787,0.0982847934984993
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35290,-0.0465438235622813,0.0207460084089385,-0.0872060000438008,-0.00588164708076185,0.0248998756383724
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35290,-0.124653151099208,0.0300142623072515,-0.183481105221421,-0.0658251969769955,3.3243586340398e-05
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35290,0.0152635288828387,0.0239710515385935,-0.0317197321328046,0.0622467898984819,0.524312646182663
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35290,-0.0280699726247879,0.0404150639037529,-0.107283497876143,0.0511435526265677,0.48736863335418
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35290,0.0309572564357638,0.0182191223360045,-0.00475222334280506,0.0666667362143326,0.0893395202172091
PLA2G1B,Phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,35186,-0.0266103522896943,0.0663128328642556,-0.156583504703635,0.103362800124247,0.688224538537006
PLA2G1B,Phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,35270,0.0461251715884363,0.0596427570916515,-0.0707746323112006,0.163024975488073,0.439340944327288
PLA2G1B,Phospholipase A2,Mental health,X29173.Frequency of feeling left out,35228,0.00794027947605047,0.0636000699961694,-0.116715857716441,0.132596416668542,0.90064881826257
PLA2G1B,Phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,35261,0.117772725642609,0.0660358440275999,-0.0116575286514864,0.247202979936705,0.0745603534561581
PLA2G1B,Phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,35304,-0.0529920152304693,0.0528795933549136,-0.1566360182061,0.0506519877451613,0.316322447679456
PLA2G1B,Phospholipase A2,Mental health,X29176.Ability to make it through stressful events,35304,0.0960456086457164,0.0502318585658956,-0.00240883414343901,0.194500051434872,0.0559170755597148
PLA2G1B,Phospholipase A2,Mental health,X29177.Quick recovery from stressful events,35304,-0.0465043650712828,0.0518423928632581,-0.148115455083269,0.0551067249407029,0.369736381206483
PLA2G1B,Phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,35304,0.0438402594729475,0.0504877061864968,-0.0551156446525863,0.142796163598481,0.38524490269352
PLA2G1B,Phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,35304,-0.0713805650038535,0.0517356261285662,-0.172782392215843,0.0300212622081363,0.167724058242387
PLA2G1B,Phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,35304,0.0517846996297759,0.051009662317553,-0.048194238512628,0.15176363777218,0.310053610353448
PLA2G1B,Phospholipase A2,Mental health,X29181.General happiness,35273,0.0147389582382296,0.0528665032794103,-0.0888793881894146,0.118357304665874,0.780411039429509
PLA2G1B,Phospholipase A2,Mental health,X29182.Belief that own life is meaningful,35181,0.0433679187718594,0.0531001306925188,-0.0607083373854774,0.147444174929196,0.414121186229485
PLA2G1B,Phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,35676,-0.0334983053689076,0.0446879891143891,-0.12108676403311,0.054090153295295,0.453520310232377
PLA2G1B,Phospholipase A2,Health and medical history,X2946.Father's age,30176,0.022006015684162,0.0310768077099069,-0.0389045274272554,0.0829165587955794,0.479040645580305
PLA2G1B,Phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,36901,-0.0138110684214681,0.00683685792778664,-0.0272113099599299,-0.0004108268830063,0.043408581635786
PLA2G1B,Phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51855,0.00239611858759594,0.00363208243372863,-0.00472276298251218,0.00951500015770406,0.509447096981912
PLA2G1B,Phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51856,0.00583689535397858,0.00382202553804831,-0.0016542747005961,0.0133280654085533,0.126731879743477
PLA2G1B,Phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,51856,-0.00941717583471045,0.00410608037496224,-0.0174650933696364,-0.00136925829978447,0.0218300183166785
PLA2G1B,Phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,51856,-0.0019609286375321,0.00399359329665968,-0.00978837149898507,0.00586651422392086,0.623418038506175
PLA2G1B,Phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,51856,-0.012265478171824,0.00350600841185739,-0.0191372546590644,-0.00539370168458347,0.000468926637973248
PLA2G1B,Phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51856,-0.0204691754231503,0.00351705493741409,-0.027362603100482,-0.0135757477458187,5.96489824250188e-09
PLA2G1B,Phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51856,-0.0173805375299864,0.00344403431080556,-0.0241308447791652,-0.0106302302808075,4.5330610693136e-07
PLA2G1B,Phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51856,0.0226051288954098,0.00355307217169926,0.0156411074388793,0.0295691503519404,2.02770397163542e-10
PLA2G1B,Phospholipase A2,Blood and urine assays,X30080.Platelet count,51856,-0.00598167199398085,0.00348113706081927,-0.0128047006331866,0.000841356645224924,0.0857537782550599
PLA2G1B,Phospholipase A2,Blood and urine assays,X30090.Platelet crit,51856,-0.00420664126101892,0.00354205103056126,-0.011149061280919,0.00273577875888115,0.23499219518992
PLA2G1B,Phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51856,0.00417129204278037,0.00331848760113909,-0.00233294365545225,0.010675527741013,0.208771705076648
PLA2G1B,Phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,51856,-0.0104344980239505,0.00344477347061776,-0.0171862540263613,-0.0036827420215397,0.00245575037607898
PLA2G1B,Phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,51817,-0.0167839817990688,0.00341857929776808,-0.0234843972226943,-0.0100835663754434,9.18808383872192e-07
PLA2G1B,Phospholipase A2,Blood and urine assays,X30130.Monocyte count,51817,0.00686668212429477,0.00349886286508469,8.91090872877625e-06,0.0137244533398608,0.0497110945080302
PLA2G1B,Phospholipase A2,Blood and urine assays,X30140.Neutrophill count,51817,0.00753967525539301,0.00360027807927161,0.000483130220020655,0.0145962202907654,0.0362539365822089
PLA2G1B,Phospholipase A2,Blood and urine assays,X30150.Eosinophill count,51817,0.00302042829360541,0.00343486442924329,-0.00371190598771144,0.00975276257492226,0.379223988810338
PLA2G1B,Phospholipase A2,Blood and urine assays,X30160.Basophill count,51817,0.00503640008274169,0.0269421963196539,-0.0477703047037799,0.0578431048692633,0.851714419394502
PLA2G1B,Phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,51817,0.000192576888259975,0.133830143507987,-0.262114504387394,0.262499658163914,0.998851885152307
PLA2G1B,Phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,51818,-0.0184085619298218,0.00341221011994945,-0.0250964937649227,-0.0117206300947209,6.92465305170975e-08
PLA2G1B,Phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,51818,0.00571375402408272,0.00345696425550839,-0.00106189591671373,0.0124894039648792,0.0983805320863116
PLA2G1B,Phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,51818,0.0136838154587144,0.00338670419692952,0.0070458752327325,0.0203217556846962,5.35244796998653e-05
PLA2G1B,Phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,51818,0.00314567777809945,0.00340912871755558,-0.00353621450830948,0.00982757006450838,0.356161982420925
PLA2G1B,Phospholipase A2,Blood and urine assays,X30220.Basophill percentage,51818,-0.00493169064936319,0.00340085046132814,-0.0115973575535663,0.00173397625483997,0.147034873226943
PLA2G1B,Phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51817,-0.000401213636707423,0.133781702133209,-0.262613349817798,0.261810922544383,0.997607160444119
PLA2G1B,Phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,51468,-0.0258810948687113,0.00367336071688534,-0.0330808818738065,-0.018681307863616,1.90020516456671e-12
PLA2G1B,Phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,51468,-0.0250236421678604,0.00373815484677278,-0.032350425667535,-0.0176968586681857,2.22139355415815e-11
PLA2G1B,Phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,51468,0.003413668005863,0.00343834323529404,-0.00332548473531332,0.0101528207470393,0.320806754807147
PLA2G1B,Phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,51468,-0.0134204497843208,0.00348343542313078,-0.0202479832136571,-0.00659291635498445,0.000117174749743104
PLA2G1B,Phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,51468,-0.0083389500888752,0.00362620085772056,-0.0154463037700075,-0.00123159640774291,0.0214779284369533
PLA2G1B,Phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51468,-0.0238672329234344,0.0037437967045356,-0.0312050744643242,-0.0165293913825446,1.86378779376201e-10
PLA2G1B,Phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,51468,-0.0233488615376217,0.00379342635226533,-0.0307839771880617,-0.0159137458871816,7.63185665980666e-10
PLA2G1B,Phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,37267,0.0312232842582577,0.00591499333693314,0.0196298973178688,0.0428166711986467,1.33512456112777e-07
PLA2G1B,Phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51845,0.00840359470310398,0.00378729810857005,0.000980490410306689,0.0158266989959013,0.0265041385228779
PLA2G1B,Phospholipase A2,Blood and urine assays,X30520.Potassium in urine,51807,-0.00384412692485645,0.00355642675476792,-0.0108147233642016,0.00312646951448868,0.27975497154691
PLA2G1B,Phospholipase A2,Blood and urine assays,X30530.Sodium in urine,51787,-0.0417106011536832,0.0037354680150609,-0.0490321184632026,-0.0343890838441638,7.11131235692104e-29
PLA2G1B,Phospholipase A2,Blood and urine assays,X30600.Albumin,49589,0.00266842623679609,0.00368352384226646,-0.00455128049404618,0.00988813296763835,0.468814919448132
PLA2G1B,Phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,51433,-0.00978356963266926,0.00362429654691933,-0.0168871908646312,-0.00267994840070736,0.0069508861907995
PLA2G1B,Phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,51436,-0.0230050055154371,0.00385665098158269,-0.0305640414393392,-0.015445969591535,2.48300010942409e-09
PLA2G1B,Phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,49445,-0.0380416742530882,0.00403380448765023,-0.0459479310488827,-0.0301354174572938,4.49919908522136e-21
PLA2G1B,Phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,51332,-0.0203329865907195,0.00336234691934745,-0.0269231865526405,-0.0137427866287985,1.49691229905636e-09
PLA2G1B,Phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,51369,-0.0053125645109197,0.00368598165729081,-0.0125370885592097,0.00191195953737029,0.149517197623229
PLA2G1B,Phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,48175,0.00310445932726874,0.00392179992363875,-0.0045822685230632,0.0107911871776007,0.428609414751817
PLA2G1B,Phospholipase A2,Blood and urine assays,X30670.Urea,51419,0.096013242492796,0.00350200370047885,0.0891493152398575,0.102877169745735,8.83703606551464e-163
PLA2G1B,Phospholipase A2,Blood and urine assays,X30680.Calcium,49591,0.0200831557398689,0.00356255679674802,0.0131005444182428,0.027065767061495,1.75033744848381e-08
PLA2G1B,Phospholipase A2,Blood and urine assays,X30690.Cholesterol,51440,-0.0241507876727445,0.00339437313032487,-0.0308037590081812,-0.0174978163373077,1.15351124603398e-12
PLA2G1B,Phospholipase A2,Blood and urine assays,X30700.Creatinine,51430,0.173050545360347,0.00377720103781429,0.165647231326231,0.180453859394463,0
PLA2G1B,Phospholipase A2,Blood and urine assays,X30710.C-reactive protein,51375,-0.0253894237171238,0.00386376732518797,-0.0329624076744922,-0.0178164397597553,5.10336176469452e-11
PLA2G1B,Phospholipase A2,Blood and urine assays,X30720.Cystatin C,51446,0.132961692007916,0.00380871454650747,0.125496611496762,0.140426772519071,5.31949224272562e-260
PLA2G1B,Phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,51434,-0.0388692914795036,0.003874693712452,-0.0464636911559095,-0.0312748918030977,1.24320277894637e-23
PLA2G1B,Phospholipase A2,Blood and urine assays,X30740.Glucose,49574,-0.0531578611347907,0.00363907543536201,-0.0602904489881002,-0.0460252732814811,4.4025307664519e-48
PLA2G1B,Phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),51390,-0.0235153549754037,0.0037099342351422,-0.0307868260762824,-0.016243883874525,2.36502003715106e-10
PLA2G1B,Phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,49581,-0.0262791798954699,0.00413927954023374,-0.034392167794328,-0.0181661919966117,2.21674792623171e-10
PLA2G1B,Phospholipase A2,Blood and urine assays,X30770.IGF-1,51307,0.0583432711139533,0.00351704310449143,0.0514498666291501,0.0652366755987565,1.9776376541055e-61
PLA2G1B,Phospholipase A2,Blood and urine assays,X30780.LDL direct,51388,-0.0169553866501318,0.00332721507531959,-0.0234767281977581,-0.0104340451025054,3.49806047731898e-07
PLA2G1B,Phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,46932,0.0105396257267854,0.00380398793674455,0.00308380937076609,0.0179954420828047,0.00559979316523151
PLA2G1B,Phospholipase A2,Blood and urine assays,X30810.Phosphate,49551,0.0404064273090011,0.0038099694433337,0.0329388872000671,0.0478739674179352,3.29082506422814e-26
PLA2G1B,Phospholipase A2,Blood and urine assays,X30830.SHBG,49413,0.0220414207360416,0.00442711374541753,0.0133642777950232,0.0307185636770599,6.45282108109072e-07
PLA2G1B,Phospholipase A2,Blood and urine assays,X30840.Total bilirubin,51349,0.00404675134923132,0.00373558617482606,-0.00327499755342776,0.0113685002518904,0.27868816192847
PLA2G1B,Phospholipase A2,Blood and urine assays,X30850.Testosterone,48836,-0.00141694457928419,0.00588640879918693,-0.0129543058256906,0.0101204166671222,0.809778829568445
PLA2G1B,Phospholipase A2,Blood and urine assays,X30860.Total protein,49573,0.0163909412320218,0.0035700124198589,0.00939371688909835,0.0233881655749452,4.43158623164258e-06
PLA2G1B,Phospholipase A2,Blood and urine assays,X30870.Triglycerides,51425,-0.0165746970459863,0.0038824698493642,-0.0241843379507401,-0.00896505614123245,1.97066315844227e-05
PLA2G1B,Phospholipase A2,Blood and urine assays,X30880.Urate,51404,0.0439864536436487,0.00416012090498891,0.0358326166698705,0.052140290617427,4.56801454800195e-26
PLA2G1B,Phospholipase A2,Blood and urine assays,X30890.Vitamin D,50305,0.0283387702766446,0.00394639014878697,0.0206038455850221,0.036073694968267,7.15340473964756e-13
PLA2G1B,Phospholipase A2,Physical measures,X3137.Number of measurements made,49961,0.0237440623900414,0.0319571720335603,-0.0388919947957367,0.0863801195758196,0.45749229124699
PLA2G1B,Phospholipase A2,Physical measures,X3143.Ankle spacing width,42419,-0.0227560107781038,0.00594081720804632,-0.0344000125058746,-0.0111120090503331,0.000128499342042384
PLA2G1B,Phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42418,-0.00412470729490124,0.00462639540193018,-0.0131924422826844,0.0049430276928819,0.372645247013015
PLA2G1B,Phospholipase A2,Physical measures,X3146.Speed of sound through heel,42419,0.00276146128221912,0.0044299041604608,-0.00592115087228404,0.0114440734367223,0.533053355162556
PLA2G1B,Phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42419,0.000472362979484516,0.00448472183841662,-0.00831769182381205,0.00926241778278108,0.916117815851951
PLA2G1B,Phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),42407,0.000671435682119102,0.00449190696888123,-0.0081327019768881,0.0094755733411263,0.881179730656091
PLA2G1B,Phospholipase A2,Health and medical history,X3526.Mother's age at death,48558,-0.000318437323728637,0.00355708869490073,-0.00729033116573406,0.00665345651827678,0.928668078904017
PLA2G1B,Phospholipase A2,Health and medical history,X3581.Age at menopause (last menstrual period),38595,-0.000958000763682199,0.00470143216625457,-0.0101728078095412,0.00825680628217675,0.838539321191231
PLA2G1B,Phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32844,-0.000953804156086664,0.007307573696105,-0.0152766486004525,0.0133690402882791,0.89616009860215
PLA2G1B,Phospholipase A2,Physical measures,X4100.Ankle spacing width (left),36854,-0.00912677541960738,0.00790701090177394,-0.0246245167870843,0.00637096594786955,0.248428096047142
PLA2G1B,Phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36851,0.00465630781934452,0.00614110434131705,-0.00738025668963689,0.0166928723283259,0.448342656378317
PLA2G1B,Phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),36854,0.00729807454974726,0.0058697417484741,-0.00420661927726197,0.0188027683767565,0.213781259566572
PLA2G1B,Phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36854,0.00710895554089164,0.00594816606492532,-0.00454944994636199,0.0187673610281453,0.232065110376565
PLA2G1B,Phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36849,0.00713852064545107,0.00594950598696844,-0.00452251108900707,0.0187995523799092,0.230234350030482
PLA2G1B,Phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36854,0.00710703681395358,0.00594814882535556,-0.00455133488374333,0.0187654085116505,0.232189782596843
PLA2G1B,Phospholipase A2,Physical measures,X4119.Ankle spacing width (right),36853,-0.006537386502458,0.0077927465928079,-0.0218111698243615,0.00873639681944548,0.401547908927073
PLA2G1B,Phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36852,-0.00113232840660792,0.00612931937280663,-0.0131457943773089,0.0108811375640931,0.853438125514033
PLA2G1B,Phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),36853,0.00171008652111779,0.00585236453695288,-0.00976054797130986,0.0131807210135454,0.770138281472809
PLA2G1B,Phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36853,0.000681846817849039,0.00593282982025504,-0.0109464996298508,0.0123101932655489,0.908505397471519
PLA2G1B,Phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36848,0.000471486560485125,0.00592983543335839,-0.0111509908888973,0.0120939640098676,0.936628339620693
PLA2G1B,Phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36853,0.000683641439418617,0.00593283645386933,-0.0109447180101653,0.0123120008890025,0.908265748391308
PLA2G1B,Phospholipase A2,Physical measures,X4194.Pulse rate,37207,-0.0322699090562543,0.00562750591806977,-0.0432998206556711,-0.0212399974568376,1.01460232198102e-08
PLA2G1B,Phospholipase A2,Physical measures,X4195.Pulse wave reflection index,37207,0.00714061383600705,0.00609162570958868,-0.00479897255478677,0.0190802002268009,0.241150946757325
PLA2G1B,Phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,37201,0.0116120706461603,0.00556854170281225,0.000697728908648299,0.0225264123836723,0.037073822792903
PLA2G1B,Phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,37207,-0.0305353646775214,0.00593530397715744,-0.04216856047275,-0.0189021688822928,2.74300279981372e-07
PLA2G1B,Phospholipase A2,Physical measures,X4199.Position of pulse wave notch,37207,-0.0221796748518244,0.00568883331625241,-0.0333297881516791,-0.0110295615519697,9.74558056351726e-05
PLA2G1B,Phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,37207,-0.0248246244241871,0.00584699735179833,-0.0362847392337118,-0.0133645096146623,2.20367152405708e-05
PLA2G1B,Phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),37014,-0.151607814737985,0.121289009797771,-0.389334273941615,0.0861186444656461,0.211347403120952
PLA2G1B,Phospholipase A2,Physical measures,X4270.Volume level set by participant (left),36924,0.00954912312808086,0.0410993272462051,-0.0710055582744811,0.0901038045306429,0.816278107655377
PLA2G1B,Phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),37012,-0.0192358119050136,0.119175359031713,-0.252819515607172,0.214347891797145,0.871776537607428
PLA2G1B,Phospholipase A2,Physical measures,X4277.Volume level set by participant (right),36917,0.0628491025432189,0.0410381396191306,-0.017585651110277,0.143283856196715,0.125691704914962
PLA2G1B,Phospholipase A2,Cognitive function,X4288.Time to answer,37208,0.00384590752207391,0.00669108875920715,-0.00926862644597211,0.0169604414901199,0.565455872817916
PLA2G1B,Phospholipase A2,Cognitive function,X4290.Duration screen displayed,37208,-0.00801111509370309,0.0062990441983542,-0.0203572417224773,0.00433501153507114,0.203481619852105
PLA2G1B,Phospholipase A2,Physical measures,X46.Hand grip strength (left),52465,-0.0187451320056233,0.0048775283315211,-0.0283050875354047,-0.00918517647584196,0.000121781843858855
PLA2G1B,Phospholipase A2,Physical measures,X47.Hand grip strength (right),52491,-0.0199335604472116,0.00483972409642177,-0.0294194196761983,-0.010447701218225,3.82265325559792e-05
PLA2G1B,Phospholipase A2,Physical measures,X48.Waist circumference,52557,-0.0787490106301896,0.00736800808938562,-0.0931903064853854,-0.0643077147749938,1.33515413647549e-26
PLA2G1B,Phospholipase A2,Health and medical history,X4803.Tinnitus,37107,-0.0277754167224797,0.0456186141499161,-0.117187900456315,0.0616370670113559,0.54263374616458
PLA2G1B,Phospholipase A2,Working and living environment,X4825.Noisy workplace,37189,-0.0799838416478729,0.0519723311925155,-0.181849610785203,0.0218819274894573,0.123851283730895
PLA2G1B,Phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,37145,-0.0283804161862576,0.0851786674113807,-0.195330604312564,0.138569771940049,0.739001993041087
PLA2G1B,Phospholipase A2,Physical measures,X49.Hip circumference,52552,-0.0176021869302788,0.00601471226646932,-0.0293910229725587,-0.00581335088799896,0.00343105635298346
PLA2G1B,Phospholipase A2,Physical measures,X50.Standing height,52531,-0.0350904371254269,0.00477918972873933,-0.044457648993756,-0.0257232252570978,2.1676603378374e-13
PLA2G1B,Phospholipase A2,Health and medical history,X5057.Number of older siblings,35959,0.0583466027019402,0.0450415995645375,-0.0299349324445533,0.146628137848434,0.195228670113389
PLA2G1B,Phospholipase A2,Physical measures,X51.Seated height,52438,-0.0168408427399348,0.00446760818193272,-0.025597354776523,-0.00808433070334671,0.000163950879904856
PLA2G1B,Phospholipase A2,Eye measures,X5181.Ever had eye surgery,34570,-0.108270001398476,0.0908819116648291,-0.286398548261541,0.0698585454645888,0.233578169054842
PLA2G1B,Phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),34555,-0.0069751943859077,0.00684293434564664,-0.0203873457033751,0.00643695693155971,0.308093285751951
PLA2G1B,Phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),34555,-0.00185250204375657,0.00702089088758382,-0.0156134481834209,0.0119084440959077,0.791901257941286
PLA2G1B,Phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),34481,0.00192699877751188,0.00721585663790394,-0.0122160802327798,0.0160700777878036,0.789440624905257
PLA2G1B,Phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),34480,0.00154999335723131,0.00727510788383783,-0.0127092180950908,0.0158092048095534,0.831292789030464
PLA2G1B,Phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",34538,-0.0389845635688529,0.0528255716141324,-0.142522683932552,0.0645535567948466,0.460555007416604
PLA2G1B,Phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),34538,-0.179269720930236,0.296459275486438,-0.760329900883653,0.401790459023182,0.545402244408719
PLA2G1B,Phospholipase A2,Eye measures,"X5201.logMAR, final (right)",34481,-0.00218232385723328,0.00757610607255258,-0.0170314917594363,0.0126668440449698,0.773317078637643
PLA2G1B,Phospholipase A2,Eye measures,X5202.Number of rounds to result (right),34538,-0.0738745005851809,0.0486382987049765,-0.169205566046935,0.021456564876573,0.128858392871553
PLA2G1B,Phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",34536,0.00083677613279888,0.0532695260945985,-0.103571495012614,0.105245047278212,0.987467655609765
PLA2G1B,Phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),34536,0.249447203249204,0.272859810635249,-0.285358025595885,0.784252432094292,0.360655418666659
PLA2G1B,Phospholipase A2,Eye measures,"X5208.logMAR, final (left)",34475,-0.00468025746950583,0.00755862133727264,-0.0194951552905602,0.0101346403515485,0.535814882611834
PLA2G1B,Phospholipase A2,Eye measures,X5209.Number of rounds to result (left),34534,0.0198280422198158,0.0484726178432298,-0.0751782887529147,0.114834373192546,0.682514594213772
PLA2G1B,Phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",34276,0.00903618178985404,0.0070388934361191,-0.00476004934493939,0.0228324129246475,0.199287854797497
PLA2G1B,Phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",34276,0.00538645425994745,0.00711674580387049,-0.00856236751563871,0.0193352760355336,0.449162595920222
PLA2G1B,Phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),34276,-0.00956289265927935,0.00710857865812529,-0.0234957068292049,0.0043699215106462,0.178601030479979
PLA2G1B,Phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),34276,-0.00471285752911639,0.00717980322943461,-0.0187852718588082,0.00935955680057545,0.511593401938625
PLA2G1B,Phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",34269,0.00419480231125134,0.00699807864152097,-0.00952143182612975,0.0179110364486324,0.548918266631403
PLA2G1B,Phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",34269,0.00394857971996004,0.0070788009190788,-0.00992587008143442,0.0178230295213545,0.577003196110291
PLA2G1B,Phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),34269,-0.000961624799849971,0.0071719559778765,-0.0150186585164879,0.013095408916788,0.893343645200035
PLA2G1B,Phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),34269,0.00274804093394045,0.00721010357797233,-0.0113837620788853,0.0168798439467662,0.703117168568395
PLA2G1B,Phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34680,0.075427490021303,0.281491512877704,-0.476295875218996,0.627150855261602,0.788742852557619
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52495,-0.0208633880738605,0.0180242652980712,-0.0561909480580801,0.0144641719103591,0.247073185767971
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52495,-0.0294274020056503,0.0191599423223048,-0.0669808889573676,0.00812608494606699,0.124581010428959
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52495,0.0268394714480036,0.0510862874947456,-0.0732896520416978,0.126968594937705,0.599327349283525
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52495,-0.0319756437598702,0.00777012016094496,-0.0472050792753223,-0.0167462082444181,3.88163805325844e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52495,0.0334225770519164,0.00731414986909474,0.0190868433084907,0.0477583107953421,4.91214042298156e-06
PLA2G1B,Phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38420,0.00344544073133117,0.0108619420618481,-0.0178439657098911,0.0247348471725534,0.751096742781041
PLA2G1B,Phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38420,-0.0266172762282075,0.0232309039934142,-0.0721498480552994,0.0189152955988844,0.251919989396645
PLA2G1B,Phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38420,-0.0223321195223422,0.0286561591052141,-0.078498191368562,0.0338339523238775,0.435815302496228
PLA2G1B,Phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38420,-0.0167306775992637,0.0154283753897484,-0.0469702933631707,0.0135089381646432,0.278211587942314
PLA2G1B,Phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52569,0.00106551003890241,0.0151709004375358,-0.0286694548186678,0.0308004748964727,0.944008170326238
PLA2G1B,Phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52569,0.00106551003890241,0.0151709004375358,-0.0286694548186678,0.0308004748964727,0.944008170326238
PLA2G1B,Phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52569,-0.00370285287331804,0.0121777570903049,-0.0275712567703156,0.0201655510236795,0.76107962856167
PLA2G1B,Phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52569,0.0100851478976211,0.0210734075920818,-0.0312187309828592,0.0513890267781013,0.63224744628505
PLA2G1B,Phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52569,0.0186273079593036,0.0502036378305766,-0.0797718221886266,0.117026438107234,0.710614807898434
PLA2G1B,Phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52569,-0.0201402487602599,0.0342707071610558,-0.0873108347959292,0.0470303372754094,0.556752004000445
PLA2G1B,Phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52569,-0.100356364009598,0.0569947619647738,-0.212066097460555,0.0113533694413582,0.0782853724104798
PLA2G1B,Phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52495,0.00240723971963954,0.0112299489722896,-0.0196034602660481,0.0244179397053272,0.830269050870042
PLA2G1B,Phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52495,-0.00454839850676592,0.018949151259218,-0.0416887349748331,0.0325919379613013,0.810307731252379
PLA2G1B,Phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52495,-0.0161719264560462,0.0112611517824622,-0.0382437839496722,0.00589993103757979,0.150992709876319
PLA2G1B,Phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52495,-0.0039307908039762,0.0159156357540435,-0.0351254368819014,0.027263855273949,0.80492845125093
PLA2G1B,Phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52495,-0.0244982217827056,0.0192721836636439,-0.0622717017634476,0.0132752581980364,0.203680864681485
PLA2G1B,Phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52495,-0.00725929653019048,0.00751727737998227,-0.0219931601949557,0.00747456713457477,0.334213546182187
PLA2G1B,Phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,38997,0.074824553743721,0.0185153931335121,0.0385343832020372,0.111114724285405,5.35827777462849e-05
PLA2G1B,Phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,38997,-0.00422758334726247,0.0158754694879104,-0.0353435035435669,0.026888336849042,0.790016401769519
PLA2G1B,Phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,38997,0.0840614402531372,0.0228358429781766,0.039303188015911,0.128819692490363,0.000233459644806248
PLA2G1B,Phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,38997,-0.000644768166732958,0.017915774084335,-0.0357596853720295,0.0344701490385636,0.971291979675517
PLA2G1B,Phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52487,-0.0461195645449446,0.0257995909410743,-0.0966867627894502,0.00444763369956106,0.0738522112753478
PLA2G1B,Phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52487,-0.0229809719347222,0.039381084363012,-0.100167897286226,0.0542059534167813,0.559526363281579
PLA2G1B,Phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52487,0.0290191754809222,0.0621612820320007,-0.0928169373017991,0.150855288263644,0.640620994010936
PLA2G1B,Phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52487,-0.0184246342095038,0.0646119900043768,-0.145064134618082,0.108214866199075,0.775525532315939
PLA2G1B,Phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52487,0.0355849580173032,0.0213232818264423,-0.00620867436252369,0.07737859039713,0.0951642766953377
PLA2G1B,Phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52487,-0.048255259245512,0.0296099061383996,-0.106290675276775,0.00978015678575135,0.103178473270457
PLA2G1B,Phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52487,-0.00475444739112469,0.015559118002551,-0.0352503186761246,0.0257414238938752,0.759932461021068
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",36098,-0.039178385435505,0.0205723566817049,-0.0795002045316467,0.0011434336606366,0.0568971691225237
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",36098,0.0167992775021313,0.0215624093996171,-0.0254630449211183,0.0590615999253809,0.435947395039713
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",36098,0.0600951375463946,0.0301202691693073,0.00105940997455236,0.119130865118237,0.0460632873735153
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",36098,-0.0363813819713264,0.0126221167733744,-0.0611207308471402,-0.0116420330955126,0.00395936724793818
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",40705,0.0214137190782692,0.0103551548677418,0.00111761553749533,0.041709822619043,0.0386690419496494
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",40705,-0.0230019178990268,0.0122362327930571,-0.0469849341734188,0.000981098375365159,0.0601578181910452
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",40705,-0.0111434149222696,0.0101341596306737,-0.03100636779839,0.00871953795385089,0.271534040571149
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",40705,0.00497576391580292,0.0233540068095918,-0.040798089430997,0.0507496172626029,0.831285298437458
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",40705,-0.0225050701543188,0.0129951689076671,-0.0479756012133463,0.00296546090470877,0.0833354662458362
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",40705,-0.0297070304629503,0.0186344991625997,-0.0662306488216457,0.00681658789574519,0.110919759720697
PLA2G1B,Phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52495,0.00288248315418605,0.0210549489237699,-0.0383852167364029,0.044150183044775,0.891108744848865
PLA2G1B,Phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52495,0.0101665924246618,0.0158934993285861,-0.0209846662593671,0.0413178511086906,0.522393545721949
PLA2G1B,Phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52495,0.0845686288982285,0.0398015406242232,0.00655760927475103,0.162579648521706,0.0336173339315017
PLA2G1B,Phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52495,-0.00173215921723877,0.0148490838963038,-0.0308363636539941,0.0273720452195166,0.907137694425525
PLA2G1B,Phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52495,-0.00858477193112522,0.0174734801837336,-0.0428327930912431,0.0256632492289926,0.623216838546901
PLA2G1B,Phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52495,0.020421838563906,0.0208835458692881,-0.0205099113398987,0.0613535884677108,0.328138223242064
PLA2G1B,Phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52495,0.01887280081498,0.00703029704228981,0.00509341861209197,0.032652183017868,0.00726907311376214
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,35001,-0.00597858990334063,0.0183115893528692,-0.0418693050349643,0.0299121252282831,0.744063803018577
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,35001,-0.0340420379051105,0.0225100585230018,-0.0781617526101941,0.0100776767999731,0.130511105264197
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,35001,0.0194256424009709,0.015727817802796,-0.0114008804925092,0.050252165294451,0.216838171979775
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,35001,-0.0082204491717953,0.0147773355425699,-0.0371840268352323,0.0207431284916417,0.578035663211163
PLA2G1B,Phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52594,-0.00512664768976168,0.00939555662434275,-0.0235419386734735,0.0132886432939501,0.585314513643155
PLA2G1B,Phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52594,-0.0121644620765122,0.0262297629694386,-0.0635747974966117,0.0392458733435874,0.642819997093791
PLA2G1B,Phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52594,0.00140230778462387,0.00781623703444765,-0.0139175168028935,0.0167221323721413,0.857617664954498
PLA2G1B,Phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52594,-0.00553161932741259,0.00751971386592607,-0.0202702585046277,0.00920701984980251,0.461971998662751
PLA2G1B,Phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52594,-0.0130228966194398,0.0128230665133281,-0.0381561069855628,0.0121103137466832,0.30983819709729
PLA2G1B,Phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52594,-0.00307642045159245,0.00960080027033532,-0.0218939889814497,0.0157411480782648,0.748642404209451
PLA2G1B,Phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52594,-0.0183272577482358,0.00786113464518042,-0.0337350816527894,-0.00291943384368219,0.0197420065696331
PLA2G1B,Phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52594,-0.0297603454742069,0.0240168409784683,-0.0768333537920046,0.0173126628435909,0.21530427831715
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45849,0.0107823297488695,0.00805650710756554,-0.00500842418195893,0.026573083679698,0.180804544000437
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45849,-0.0433210833044009,0.00836628478650322,-0.0597190014859472,-0.0269231651228546,2.26820748101431e-07
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45849,0.0189102989267769,0.00886270382526164,0.00153939942926405,0.0362811984242897,0.0328823965674985
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45849,-0.00594415461340879,0.0121136667936321,-0.0296869415289276,0.0177986323021101,0.623646377461606
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45849,0.0050891290413126,0.00808742256530797,-0.010762219186691,0.0209404772693162,0.529184448207487
PLA2G1B,Phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52357,-0.00180520749663792,0.00821928623565424,-0.0179150085185202,0.0143045935252444,0.826160724147465
PLA2G1B,Phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52357,0.00439466157418343,0.00667814369954037,-0.00869450007691569,0.0174838232252825,0.510502044508645
PLA2G1B,Phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52357,0.00904706164312163,0.00690779625369157,-0.00449221901411384,0.0225863423003571,0.190314208950736
PLA2G1B,Phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52357,-0.0156127280198557,0.0149935037428514,-0.0449999953558445,0.0137745393161331,0.297747434911626
PLA2G1B,Phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52376,0.00246143117926469,0.00742639561683195,-0.0120943042297259,0.0170171665882553,0.740312444304655
PLA2G1B,Phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52376,0.0275007264711634,0.0147204664089192,-0.0013513876903182,0.056352840632645,0.0617472662970447
PLA2G1B,Phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52495,-0.0185709398727331,0.00679227988387312,-0.0318838084451244,-0.00525807130034182,0.0062593599023768
PLA2G1B,Phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52495,-0.0215784322370809,0.0077882202887398,-0.036843344003011,-0.00631352047115094,0.0055988850596582
PLA2G1B,Phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52495,0.0238777840586634,0.0118160732237873,0.000718280540040282,0.0470372875772865,0.0433130857968615
PLA2G1B,Phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52495,0.0166237977767772,0.0162404666897132,-0.0152075169350606,0.048455112488615,0.306033240338535
PLA2G1B,Phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52495,0.0249330458025294,0.0204848174429229,-0.0152171963855994,0.0650832879906583,0.223560400682982
PLA2G1B,Phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52495,-0.0425713520042516,0.0194859290940026,-0.0807637730284967,-0.0043789309800066,0.0289191116525176
PLA2G1B,Phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42419,0.000472213378716166,0.00448469962924031,-0.00831779789459484,0.00926222465202717,0.916143870151739
PLA2G1B,Phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,51995,-0.0309635577968016,0.0246695828134367,-0.0793159401111374,0.0173888245175343,0.209444080713895
PLA2G1B,Phospholipase A2,Physical activities,X874.Duration of walks,48856,0.00167427205451438,0.00370037023244106,-0.00557845360107009,0.00892699771009885,0.65094212876461
PLA2G1B,Phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,51045,-0.089790620858761,0.0239062760601632,-0.136646921936681,-0.0429343197808411,0.00017313790918606
PLA2G1B,Phospholipase A2,Physical activities,X894.Duration of moderate activity,46120,-0.0726065018233153,0.0298215331009642,-0.131056706701205,-0.0141562969454256,0.0149143821357596
PLA2G1B,Phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33538,4.62359412492442e-05,0.00838275695542661,-0.0163839676913869,0.0164764395738854,0.995599462831057
PLA2G1B,Phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50951,-0.0454631173829891,0.0246152770831873,-0.0937090604660362,0.00278282570005801,0.0647683644456491
PLA2G1B,Phospholipase A2,Physical activities,X914.Duration of vigorous activity,40527,0.00473859385814801,0.00448529797700405,-0.00405259017677992,0.0135297778930759,0.290774928991828
